Právní předpis byl sestaven k datu 03.06.2021.
Zobrazené znění právního předpisu je účinné od 03.06.2021 do 30.06.2022.
Příloha č. 1 - Seznam č. 1 omamných látek
Příloha č. 2 - Seznam č. 2 omamných látek
Příloha č. 3 - Seznam č. 3 omamných látek
Příloha č. 4 - Seznam č. 4 psychotropních látek
Příloha č. 5 - Seznam č. 5 psychotropních látek
Příloha č. 6 - Seznam č. 6 psychotropních látek
Příloha č. 7 - Seznam č. 7 psychotropních látek
Příloha č. 8 - Seznam č. 8 vybraných přípravků
č. 46/2017 Sb. - Čl. II
č. 30/2018 Sb. - Čl. II
č. 242/2018 Sb. - Čl. II
č. 194/2021 Sb. - Čl. II
463
XXXXXXXX VLÁDY
ze xxx 18. xxxxxxxx 2013
x xxxxxxxxx xxxxxxxxxx látek
Vláda xxxxxxxx podle §44c xxxx. 1 xxxxxx x. 167/1998 Xx., x xxxxxxxxxx xxxxxxx x x změně xxxxxxxxx xxxxxxx xxxxxx, xx xxxxx xxxxxx x. 273/2013 Xx.:
§1
Toto nařízení stanoví
a) x příloze č. 1 k xxxxxx xxxxxxxx xxxxxx
1. xxxxxxxx látek xxxxxxxxxx xx Xxxxxxx X xxxxx Xxxxxxxx úmluvy x omamných látkách1) x
2. xxxxxxx xxxxxxxx xxxxx, s xxxxx xx z xxxxxx xxxxxxx xxxxxx zneužívání xxxxx proto, xx xxxxxxxxxxxxx nebo nepřímo xxxxxxxx xxxxxx, nezbytné xxxxxxx xxxxxxxxx xxx xx xxxxxxx povolení x zacházení, nebo xx x xxxxxx xxxxxx xxxxx zabezpečit, xxx xxxxxx přípravky xxxxxxxxxx xxxx xxxxxx xxxxx byly xxxxxxxx x xxxxxxx xxxxx xx recept xxxx xxxxxxx xxxxxxxx modrým xxxxxx xxxxxxxxxx x xxxxxx xxxxxxx rohu xx xxxxxxx xxxxxxx xxxx,
(xxxx jen "xxxxxx x. 1 omamných xxxxx"),
x) v příloze č. 2 x tomuto xxxxxxxx xxxxxx
1. xxxxxxxx xxxxx xxxxxxxxxx xx Xxxxxxx XX xxxxx Jednotné xxxxxx x xxxxxxxx xxxxxxx x
2. xxxxxxx xxxxxxxx xxxxx, u xxxxx xx z xxxxxx xxxxxxx xxxxxx xxxxxxxxxx xxxxx xxxxx, xx xxxxxxxxxxxxx xxxx xxxxxxx xxxxxxxx xxxxxx, xxxxx xxxxxxxxxx, xxx xxxxxx xxxxxxxxx xxxxxxxxxx xxxx omamné látky xxxx xxxxxxxx v xxxxxxx xx xxxxxx xxxx žádanku xxx xxxxxxxx xxxxxx xxxxxx,
(xxxx xxx "xxxxxx č. 2 xxxxxxxx látek"),
c) x příloze č. 3 k xxxxxx xxxxxxxx xxxxxx
1. xxxxxxxx xxxxx xxxxxxxxxx xx Xxxxxxx XX xxxxx Xxxxxxxx xxxxxx x omamných látkách x
2. xxxxxxx xxxxxxxx xxxxx, x xxxxx xx z xxxxxx xxxxxxx xxxxxx zneužívání xxxxx xxxxx, xx xxxxxxxxxxxxx xxxx xxxxxxx xxxxxxxx xxxxxx, xxxxx xxxxxxxxxx, xxx xxxxx x přípravky obsahující xxxx xxxxxx xxxxx xxxx používány xxxxx x omezeným výzkumným, xxxxxxxx a xxxxx xxxxxxxx xxxxxxxxxxxxx xxxxxx xxxxxxxxx x povolení x zacházení,
(dále jen "xxxxxx x. 3 xxxxxxxx xxxxx"),
x) v příloze č. 4 x xxxxxx xxxxxxxx xxxxxx
1. xxxxxxxxxxxxxx xxxxx xxxxxxxxxx xx Xxxxxxx X xxxxx Xxxxxx x xxxxxxxxxxxxxx xxxxxxx2) a
2. dalších xxxxxxxxxxxxxx xxxxx, u xxxxx xx z xxxxxx xxxxxxx xxxxxx xxxxxxxxxx xxxxx proto, xx bezprostředně xxxx xxxxxxx xxxxxxxx xxxxxx, xxxxx zabezpečit, xxx xxxxx a xxxxxxxxx xxxxxxxxxx xxxx xxxxxxxxxxxx xxxxx byly xxxxxxxxx xxxxx x xxxxxxxx xxxxxxxxx, xxxxxxxx x xxxxx xxxxxxxx terapeutickým xxxxxx xxxxxxxxx x xxxxxxxx x xxxxxxxxx,
(xxxx xxx "xxxxxx č. 4 xxxxxxxxxxxxxx xxxxx"),
x) x příloze č. 5 x xxxxxx xxxxxxxx xxxxxx
1. xxxxxxxxxxxxxx xxxxx zařazených xx Seznamu II xxxxx Xxxxxx x xxxxxxxxxxxxxx xxxxxxx x
2. xxxxxxx xxxxxxxxxxxxxx xxxxx, x xxxxx xx x xxxxxx xxxxxxx xxxxxx zneužívání xxxxx xxxxx, že bezprostředně xxxx xxxxxxx xxxxxxxx xxxxxx, xxxxxxxx umožnit xxxxxxxxx jen xx xxxxxxx xxxxxxxx x xxxxxxxxx, nebo je x tohoto xxxxxx xxxxx xxxxxxxxxx, aby xxxxxx xxxxxxxxx xxxxxxxxxx xxxx psychotropní látky xxxx xxxxxxxx v xxxxxxx pouze xx xxxxxx xxxx xxxxxxx xxxxxxxx modrým xxxxxx xxxxxxxxxx x xxxxxx xxxxxxx rohu xx xxxxxxx xxxxxxx xxxx,
(xxxx xxx "xxxxxx x. 5 psychotropních látek"),
f) x příloze č. 6 k xxxxxx xxxxxxxx xxxxxx xxxxxxxxxxxxxx xxxxx zařazených xx Xxxxxxx XXX xxxxx Xxxxxx x xxxxxxxxxxxxxx látkách,
x) v příloze č. 7 k tomuto xxxxxxxx xxxxxx
1. xxxxxxxxxxxxxx xxxxx xxxxxxxxxx xx Xxxxxxx XX xxxxx Xxxxxx x psychotropních xxxxxxx x
2. xxxxxxx xxxxxxxxxxxxxx látek, x xxxxx je x xxxxxx xxxxxxx xxxxxx xxxxxxxxxx xxxxx xxxxx, xx bezprostředně xxxx xxxxxxx xxxxxxxx zdraví, xxxxx xxxxxxxxxx, xxx xxxxxx xxxxxxxxx obsahující xxxx xxxxx byly xxxxxxxx v lékárně xx recept xxxx xxxxxxx xxx xxxxxxxx xxxxxx pruhem,
(dále xxx "xxxxxx č. 7 xxxxxxxxxxxxxx xxxxx"), x
x) x příloze č. 8 x xxxxxx xxxxxxxx seznam xxxxxxxxx zařazených xx Xxxxxxx III xxxxx Xxxxxxxx xxxxxx x xxxxxxxx xxxxxxx,
(xxxx xxx "xxxxxx č. 8 xxxxxxxxx xxxxxxxxx").
§2
(1) Xxxx xxxxxxxx xxxx oznámeno v xxxxxxx xx xxxxxxxx Xxxxxxxxxx xxxxxxxxxx x Xxxx 98/34/ES xx xxx 22. xxxxxx 1998 x xxxxxxx xxx xxxxxxxxxxx xxxxxxxxx x oblasti xxxxx x xxxxxxxxxxx xxxxxxxx x xxxxxxxx xxx xxxxxx informační xxxxxxxxxxx, x xxxxxxx znění.
(2) Xxxx xxxxxxxx xxxxxxxxxxx xxxxxxxxx xxxxxxxx Evropské xxxx xxxxxxxx xx xxxxxxxxxx xxxxx3).
§3
Xxxx xxxxxxxx xxxxxx xxxxxxxxx xxxx 1. xxxxx 2014.
Xxxxxxx x. 1 x nařízení vlády x. 463/2013 Xx.
Xxxxxx x. 1 xxxxxxxx xxxxx
Xxxxxxxxxxx xxxxxxxxxx xxxxx (XXX) x českém xxxxxx |
Xxxxxxxx xxxxx podle XXXXX |
Xxxxxxxx |
Xxxxxxxxx |
(5X,6X,7X)-7-[(2X)-2-xxxxxxxxxxxxx-2-xx]-6-xxxxxxx-17-xxxxxx-4,5-xxxxx- 6,14-xxxxxxxxxxxxx-3-xx-xxxxxx |
|
XxxxxX-xxxx-xxxxxxxxxxxxxx |
(XX)-X-[1-(2-xxxxX-2-xxxxxxxxxxx)-4-xxxxxxxxx]xxxxxxxxxx |
|
XxxxxXxxxxxxxx |
(3XX)-6-(xxxxxxxxxxxxxx)-4,4-xxxxxxxxxxxxx-3-xx-xxxxxx |
|
Xxxxxxxxxxxxxxxxx |
(3X,6X)-6-(xxxxxxxxxxxxx)-4,4-xxxxxxxxxxxxx-3-xx-xxxxxx |
|
Xxxxxxxxxxxx |
(3XX,4Xx)-3-xxxxx-4-xxxxx-1-xxxxxxxxxxxxxxx-4-xx-xxxxxxxxx |
|
Xxxxxxxxxxxxx |
(3X,6X)-6-(xxxxxxxxxxxxx)-4,4-xxxxxxxxxxxxx-3-xx |
|
Xxxx-xxxxxxxxxxxxxx |
X-{1-[(1XX)-2-xxxxx-1-xxxxxxxxxxx]xxxxxxxxx-4-xx}xxxxxxxxxxxx |
|
Xxxx-xxxxxxxxxxxxxxxxxx |
X-{1-[(1XX)-1-xxxxxx-2-(2-xxxxxxx)xxxxx]xxxxxxxxx-4-xx}xxxxxxxxxxxx |
|
XXxxxxxxxx |
(3X,4XX)-4-xxxxx-1,3-xxxxxxxxxxxxxxxxx-4-xX-xxxxxxxxx |
|
Xxxxxxxxxx |
X-{1-[2-(4-xxxxx-5-xxx-4,5-xxxxxxx-1X-xxxxxxxx-1-xx)xxxxx]-4-(xxxxxxxxxxxxx) xxxxxxxxx-4-xx}-X-xxxxxxxxxxxxxxx |
|
Xxxxxxxxxxx |
3-xxxxx-4-xxxxx-1-xxxxxxxxxxxxxxx-4-xx-xxxxxxxxx |
|
Xxxxxxxxxx |
xxxxx-1-(4-xxxxxxxxxxxxx)-4-xxxxxxxxxxxxxx-4-xxxxxxxxxx |
|
Xxxxxxxxxxx |
xxxxx-1-[2-(xxxxxxxxx)xxxxx]-4-xxxxxxxxxxxxxx-4-xxxxxxxxxx |
|
Xxxxxxxxxxxx |
3-(xxxxxxXxxx)-4.5α-xxxxx-17-xxxxxxxxxxxx-7-xx-6α-xx |
|
Xxxxxxxxxxxxxxxxxx |
(3X,6X)-6-{xxxxxxxxxxxxx )-4.4-xxxxxxxxxxxxx-3-xx-xxxxxx |
|
Xxxx-xxxxxxxxxxxxxxx |
X-{1-[(2XX)-2-xxxxxxxxxxxxxxx]xxxxxxxxx-4-xx}xxxxxxxxxxxx |
|
Xxxx-xxxxxxxxxxxxxxxxxxxxx |
X-{1-[(2XX)-2-xxxxxxxxxxxxxxx]-3-xxxxxxxxxxxxxxx-4-xx}xxxxxxxxxxxx |
|
Xxxxxxxxxxxx |
(3XX,4XX)-3-xxxxx-4-xxxxX-1-xxxxxxxxxxxxxxx-4-xx-xxxxxxxxx |
|
Xxxxxxxxxxxx |
(3X,6X)-6-(xxxxxxxxxxxxx)-4,4-xxxxxxxxxxxxx-3-xx |
|
Xxxxxxxxxx |
(3XX,4XX)-4-xxxxx-1,3-xxxxxxxxxxxxxxxxx-4-xx-xxxxxxxxx |
|
Xxxxxxxxxx |
2,2-xxxxxxX-4-[4-(2-xxx-3-xxxxxxxxX-2,3-xxxxxxx-1X-xxxxxxxxxxxx-1-xx) xxxxxxxxxx]xxxxxxxxxxx |
|
Xxxxxxxxxxxxx |
1-[(3X)-2,2-xxxxxxx-3-xxxxxx-4-xxxxxxxxxxxxxxxxx]xxxxxxxxxx |
|
Xxxxxxxxxx |
X-[2-(X-xxxxxxxx-X-xxxxxxxxxxx)xxxxxx]xxxxxxxxxxxx |
|
Xxxxxxxxxxxxxxxxx |
3-(xxxxxxxxxxxx)-1,1-xx(2-xxxxxxx)xxx-1-xx |
|
Xxxxxxxxx |
1-(3,3-xxxxxxx-3-xxxxxxxxxx-4-xxxxxxxxxxxxxx-4-xxxxxxxxxxx kyselina |
|
Difenoxylát |
ethyl-1-(3,3-difenyl-3-kyanpropyl)-4-fenylpiperidin-4-karboxylát |
|
Dihydroetorfin |
(5R,6R,7R)-4,5-epoxy-7-[(2R)-2-hydroxypentan-2-yl]-6-methoxy-17-methyl- 6,14-xxxxxxxxxxxxxx-3-xx |
|
Xxxxxxxxxxxxx |
4,5α-xxxxx-17-xxxxxxxxxxxxxx-3,6α-xxxx |
|
Xxxxxxxxxxx |
[2-(xxxxxxxxxxxxx)xxxxx)]-2-xxxxxx-2,2-xxxxxxx-xxxxxx |
|
Xxxxxxxxxxxx |
6-(xxxxxxxxxxxxxx)-4,4-xxxxxxxxxxxxx-3-xx |
|
Xxxxxxxxxxxxxxxxxx |
X,X,1-xxxxxxxxx-3,3-xx(2-xxxxxxx)xxxxxxxxx |
|
Xxxxxxxxxx-xxxxxxx |
xxxxx-2,2-xxxxxxx-4-xxxxxxxxxxxxxxxxx |
Xxxxxxxxxxxxxxxxx |
Xxxxxxxxx |
(6XX)-4,4-xxxxxxx-6-xxxxxxxxxxxxxxxx-3-xx |
|
Xxxxxxxxxx |
(6X)-3,4-xxxxxxxxx-17-xxxxxxxxxxxxxx-6β,14-xxxx |
|
Xxxxxxx |
xxxxxxxx (1R,2R,3S,5S)-3-hydroxy-8-methyl-9-azabicyklo[3.2.1]oktan-2-karboxylová, xxxx xxxxxx a xxxxxxxx, x xxxxxxx je xxxxx xxxxxx xxxxxxx x xxxxxx |
|
Xxxxxxxxxxxxxxxxxxxxx |
X-xxxxx-X,1-xxxxxxxx-3,3-xxx(2-xxxxxxx)-2-xxxxxxxxxxxx |
|
Xxxxxxxxxx |
1-[2-(xxxxxxxxxxxx)xxxxx]-2-(4-xxxxxxxxxxxx]-5-xxxxx-1X-xxxxxxxxxxxx |
|
Xxxxxxxxxx |
xxxxx-4-xxxxx-1-[2-(2-xxxxxxxxxxxxx)xxxxx]xxxxxxxxx-4-xxxxxxxxxx |
|
Xxxxxxxxx |
4,4-xxxxxxx-6-xxxxxxxxxxxxxxx-3-xx |
|
Xxxxxxxxxxx |
X-(1-xxxxxx-2-xxxxxxxxxxxxxxx)xxxxxxxxxxxx |
|
Xxxxxxxxx |
(2XX,6X,11X)-3-xxxxxxxx-6,11-xxxxxxxx-1,2,3,4,5,6-xxxxxxxxx-2,6-xxxxxxx- 3-xxxxxxxxxx-8-xx |
|
Xxxxxxxxxx |
17-xxxxxxxXxxxxxxxx-3-xx |
|
Xxxxxxxxxxx |
xxxxx-4-xxxxx-1-(3-xxxxxxxxxxx)-3-xxxxxxxxxxxxxxxx-4-xxxxxxxxxx |
|
Xxxxxxxx |
X-(1-xxxxxxxxxxxxxxxxx-4-xx)-X-xxxxxxxxxxxxxxx |
|
Xxxxxxxxxx |
xxxxX-4-xxxxX-1-[2-(xxxxxxxxxxx)xxxxx]xxxxxxxxxx-4-xxxxxxxxxx |
|
Xxxxxxxxxx |
4,5α-xxxxx-3-xxxxxxx-17-xxxxxxXxxxxxxxx-6-xx |
|
Xxxxxxxxxxxxx |
4,5α-xxxxx-17-xxxxxxxxxxxxxx-3,6α,14-xxxxx |
|
Xxxxxxxxxxx |
4,5α-xxxxx-3-xxxxxxx-17-xxxxxxxxxxxxxxx-6-xx |
|
Xxxxxxxxxxxxxxx |
xxxxx-4-(3-xxxxxxxxxxxx)-1-xxxxxxxxxxxxxxxx-4-xxxxxxxxxx |
|
xxxxxxxxxxx |
6-(xxxxxxxxxxxxx)-4,4-xxxxxxx-5-xxxxxxxxxxx-3-xx |
|
Xxxxxxxxxxx |
xxxxxx-1-xxxxxxxx-4-(X-xxxxxxxxxxxxxxxx)xxxxxxxxx-4-xxxxxxxxxx |
|
Xxxxxxxxxx |
2-(4-xxxxxxxxxxx)-1-[2-(xxxxxxxxxxxxx)xxxxx]-5-xxxxx-1X-xxxxxxxxxxxx |
|
Xxxxxxx |
xxxxxxxx 2-{[X-(4,5α-xxxxx-3-xxxxxxx-17-xxxxxxxxxxxxxxx-6-xxxxxx) amino]oxy}octová |
|
Koka - xxxx |
Xxxxxx xxxx |
|
Xxxxxx |
(1X,2X,3X,5X)-3-(xxxxxxxxxx)-8-xxxxxx-8-xxxxxxxxxx[3.2.1]xxxxx-2- xxxxxxxxxx |
|
Xxxxxxxxxx x xxxxxxxx |
Xxxxxxxxxxx x xxxxxx xxxxxxxxx xxxxxxx xxxxxxxxxxxxxx xxxxxxx makoviny |
|
Konopí xxxxxxx a tinktura |
Extrakt x xxxxxxxx z xxxxxx |
|
Xxxxxx xxx léčebné xxxxxxx |
xxxxxx xxxxxx k xxxxxxxx xxxxxxxx xxxxxxxxx xx xxxxxxxxxxxxxxxx xxxxxxx xxxxxxxxxxxxxxxxxxxx |
|
Xxxxxxxxxxxxxxxxx |
1-xxxxx-2-[(9X,13X,14X)3-xxxxxxxxxxxxxxx-17-xx]xxxxx-1-xx |
|
Xxxxxxxxxxxxx |
(9X,13X,14X)-3-xxxxxxxx-17-xxxxxxxxxxxxxx |
Xxxxxxxxxxxxxx xxxxxxxxxxxxxxx [(+)-3-xxxxxxx-17- xxxxxxxxxxxxxx] xx xxxxx xx seznamu xxxxxxxx xxxxx uvedených v xxxx příloze |
Levomoramid |
(3R)-2,2-difenyl-3-methyl-4-morfolino-1-(pyrrolidin-1-yl)butan-1-on |
|
Levorfanol |
(9R,13R,14R)-17-methylmorfinan-3-ol |
Stereoizomerní xxxxxxxxxxx [(+)-3-xxxxxxx-17- xxxxxxxxxxxxxx] je xxxxx ze xxxxxxx xxxxxxxx xxxxx xxxxxxxxx x této xxxxxxx |
Xxxxxxxxx |
(2X,6X,11X)-3,6,11-xxxxxxxxx-1,2,3,4,5,6-xxxxxxxxx-2,6-xxxxxxxxx-3- xxxxxxxxx-8-xx |
|
Xxxxxxxx |
(6XX)-6-(xxxxxxxxxxxxx)4,4-xxxxxxxxxxxxx-3-xx |
|
Xxxxxxxx, meziprodukt |
4-(dimethylamono)-2,2-difenylpentanitril |
|
Methyldesorfin |
4,5α-epoxy-6,17-dimethylmorfin-6-en-3-ol |
|
Methyldihydromorfin |
4,5-epoxy-6,17-dimethylmorfinan-3,6-diol |
|
Metopon |
4,5-epoxy-3-hydroxy-5,17-dimethylmorfinan-6-on |
|
Moramid, meziprodukt |
2,2-difenyl-3-methyl-4-rnorfolinobutanová xxxxxxxx |
|
Xxxxxxxxxxxxxx |
X-(1-xxxxxxxx-3-xxxxxxxxxxxxxxx-4-xx)xxxxxxxxxxxx |
3-Xxxxxxxxxxxxxx |
Xxxxxxxxxxxxxxxxxx |
X-{(3XX)-3-xxxxxx-1-[2-(2-xxxxxxx)xxxxx]xxxxxxxxx-4-xx}xxxxxxxxxxxx |
3-xxxxxxxxxxxxxxxxxx |
Xxxxxxxxxx |
xxxxx-4-xxxxx-1-(3-xxxxxxxxxxxxxx)xxxxxxxxx-4-xxxxxxxxxx |
|
Xxxxxx |
4,5α-xxxxx-17-xxxxxXxxxxxx-7-xx-3,6α-xxxx |
|
Xxxxxx xxxxxxxxxxx |
4,5α-xxxxx-3,6α-xxxxxxxxx-17,17-xxxxxxxxxxxxxx-7-xx-17-xxx-xxxxxx |
x xxxx xxxxxxxx morfinu xx xxxxxxxxxx xxxxxxx xxxxxx xxxxxxxx morfin-N-oxidu (x xxxxxx-X-xxxxx) |
Xxxxxx-X-xxxx |
4,5α -xxxxx-17-xxxxxxxxxxxx-7-xx-3,6α-xxxx-17-xxxx |
|
XxxxxxxxXxxxxxx |
4-xxxxx-1-xxxxxxxxxxxxxxx-4-xx-xxxxxxxxx |
XXXX |
Xxxxxxx |
3-(xxxxxxxxx)-4,5α-xxxxx-17-xxxxxxxxxxxx-7-xx-6-xx-xxxxxxxxxxxxx |
|
Xxxxxxxxxx |
4,5α-xxxxx-17-xxxxxxxxxxxx-7-xx-3,6α-xxxx-xxxxxxxxxxx |
|
Xxxxxxxxxxxxxx |
4,4-xxxxxxx-6-(xxxxxxxxxxx)xxxxxx-3-xx-xxxxxx |
|
Xxxxxxxxxxxxx |
(9X,13X,14X)-xxxxxxxx-3-xx |
|
Xxxxxxxxxxx |
6-(xxxxxxxxxxxxx)-4,4-xxxxxxxxxxxx-3-xx |
|
Xxxxxxxxx |
4,5α-xxxxxxxxxxx-7-xx-3,6α-xxxX |
|
Xxxxxxxxxx |
4,4-xxxxxxx-6-xxxxxxxxxxxxxxx-3-xx |
|
Xxxxx |
Xxxxx xxxxxxxxxxxx xxxxxxxxxx přípavků, xxxxxxx xxxxxx ředění xx xxxxx než X4 xxxx CH2 |
|
Oripavin |
4,5α-epoxy-6-methoxy-17-methylmorfina-6,8(14)-dien-3-ol |
|
Oxykodon |
(5R)-4,5-epoxy-14-hydroxy-3-methoxy-17-methylmorfinan-6-on |
|
Oxymorfon |
(5R)-4,5-epoxy-3,14-dihydroxy-17-methylmorfinan-6-on |
|
Parafluorfentanyl |
N-(1-fenethyIpiperidin-4-yl)-4'-fluorpropanamilid |
|
Pheneridin |
ethyl-1-fenethyl-4-fenylpiperidin-4-karboxylát |
PEPAP |
Pethidin |
ethyl-4-fenyl-1-methylpiperidin-4-karboxylát |
|
Pethidin, xxxxxxxxxxx X |
4-xxxxx-1-xxxxxxxxxxxxxxx-1-xxxxxxxxxxx |
|
Xxxxxxxx, meziprodukt X |
xxxxx-4-xxxxxxxxxxxxxx-4-xxxxxxxxxx |
|
Xxxxxxxx, xxxxxxxxxxx X |
xxxxxxxx 4-xxxxx-1-xxxxxxxxxxxxxxx-4-xxxxxxxxxxx |
|
Xxxxxxxxx |
xxxxx-1-(3-xxxxxxxxxxxxx)-4-xxxxxxxxxxxxxx-4-xxxxxxxxxx |
|
Xxxxxxxxxx |
1'-(3,3-xxxxxxx-3-xxxxxxxxxx-4'-xxxxxx-1,4'-xxxxxxxxxxx |
|
Xxxxxxxxxxx |
4-xxxxx-1,3-xxxxxxxxxxxxxx-4-xx-xxxxxxxxx |
|
Xxxxxxxxxx |
xxxxxxxxX-4-xxxxx-1-xxxxxxxxxxxxxxx-4-xxxxxxxxxx |
|
Xxxxxxxxxxxxx |
(9XX,13XX,14XX)-3-xxxxxxx-17-xxxxxxxxxxxxxx |
|
Xxxxxxxxxxxx |
(3XX)-2,2-xxxxxxx-3-xxxxxx-4-xxxxxxxxx-1-(xxxxxxxxxx-1-xx)xxxxx-1-xx |
|
Xxxxxxxxxx |
(9XX,13XX,14XX)-17-xxxxxxxxxxxxxx-3-xx |
|
Xxxxxxxxxxxxx |
xxxxxx-3-[4-(X-xxxxxxxxxxxxxxx)4-(xxxxxxxxxxxxxxx)]xxxxxxxxxx]xxxxxxxxx |
|
Xxxxxxxxxx |
X-{4-(xxxxxxxxxxxxx)-1-[2-(2-xxxxxxx)xxxxx]xxxxxxxxx-4-xx}xxxxxxxxxxxx |
|
Xxxxxxxxxx |
3-[(1X,2X)-3-(xxxxxxxxxxxxx)-1-xxxxx-2-xxxxxxxxxxxx]xxxxx |
|
Xxxxxxx |
4,5α-xxxxx-3,6-xxxxxxxxx-17-xxxxxxxxxxxxxxx-6,8-xxxx |
|
Xxxxxxxx |
(5X)-4,5-xxxxx-3-xxxxxxx-17-xxxxxXxxxxxx-6-xx-6-xx-xxxxxx |
|
Xxxxxxxxxxxx |
X-{1-[2-(2-xxxxxxx)xxxxx]xxxxxxxxx-4-xx}xxxxxxxxxxxx |
|
Xxxxxxx |
xxxxx-(1XX,2XX)-2-(xxxxxxxxxxxxx)-1-xxxxxxxxxxxxx-3-xx-1-xxxxxxxxxx |
|
Xxxxxxxxxxxx |
(XX)-4-xxxxx-4-(1,2,5-xxxxxxxxxxxxxxxxxx-4-xx)xxxxxxxxx |
Xxxxxx xxxxxxx omamných xxxxx xxxxxxxxx v xxxxx xxxxxxx, xxxx xxxxxx x xxxxxx omamných xxxxx uvedených v xxxxx xxxxxxx x xxxx xxxxxxxx xxxxx xxxxxxxxx v xxxxx xxxxxxx xxxxxx xxxx xxxxxxx, xxxxxx x xxxxx ve xxxxx xxxxxxxxx, kdy tyto xxxx xxxxx existovat.
Příloha x. 2 x xxxxxxxx vlády x. 463/2013 Xx.
Xxxxxx x. 2 xxxxxxxx xxxxx
Xxxxxxxxxxx nechráněný xxxxx (XXX) x xxxxxx xxxxxx |
Xxxxxxxx xxxxx podle XXXXX |
Xxxxxxxx |
Xxxxxxxxxxxxxxxxxxx |
4,5α-xxxxx-3-xxxxxxx-17-xxxxxxxxxxxxxx-6α-xx-xxxxxx |
|
Xxxxxxxxxxxxxxxx |
(1X,2X)-1-xxxxxx-3-(xxxxxxxxxxxxx)-1-xxxxxxxxxxxx-xxxxxxxxx |
|
Xxxxxxxxxxxxx |
4,5α-xxxxx-3-xxxxxxx-17-xxxxxxxxxxxxxx-6α-xx |
|
Xxxxxxxxxxx |
4,5α-xxxxx-3-xxxxxx-17-xxxxxxxxxxxx-7-xx-6α-xx |
|
Xxxxxxxx |
4,5α-xxxxx-17-xxxxxx-3-(2-xxxxxxxxxxxxxxx)xxxxxx-7-xx-6α-xx |
|
Xxxxxx |
4,5α-xxxxx-3-xxxxxxx-17-xxxxxxxxxxxx-7-xx-6α-xx |
|
Xxxxxxxxxxx |
4,5α-xxxxx-3-xxxxxxx-17-xxxxxxxxxxxxxx-6α-xx-xxxxxxxxx |
|
Xxxxxxxxx |
4,5α-xxxxx-3-xxxxxxx-17-xxxxxxxxxxxx--7-xx-6-xx-xxxxxxxxx |
|
Xxxxxxxxx |
4,5α-xxxxx-3-xxxxxxxxxxxxx-7-xx-6α-xx |
|
Xxxxxxxx |
X-[(1XX)-1-xxxxxx-2-xxxxxxxxxxxxxxx]-X-(2-xxxxxxx)xxxxxxxxxx |
Xxxxxx xxxxxxx omamných xxxxx uvedených x xxxxx xxxxxxx, dále xxxx xxxxxxxx xxxxx xxxxxxxxx x xxxxx xxxxxxx, včetně solí xxxxxxx látek xxxxxxxxx x xxxxx xxxxxxx xx xxxxx xxxxxxxxx, xxx tyto xxxx xxxxx existovat.
Xxxxxxx x. 3 x xxxxxxxx xxxxx x. 463/2013 Sb.
Seznam x. 3 xxxxxxxx xxxxx
Xxxxxxxxxxx xxxxxxxxxx xxxxx (XXX) x českém xxxxxx / xxxxxx xxxxx |
Xxxxx xxxxxxxxxxx xxxxxxxxxx xxxxx xxxx xxxxx xxxxxx xxxxx |
Xxxxxxxx název xxxxx IUPAC |
Poznámka |
Acetylbenzylfentanyl |
NSC 73750; |
N-fenyl-N-(1-benzyl-piperidin-4-yl)-acetamid |
|
Acetylfentanyl |
N-fenyl-N-[1-(2-fenylethyl)-4-piperidinyl]acetamid |
||
Acryloylfentanyl |
Acrylfentanyl |
N-fenyl-N-[1-(2-fenylethyl)piperidin-4-yl]prop-2-enamid |
|
AH-7921 |
3,4-dichlor-N-{[1-(dimethylamino)cyklohexyl]methyl}benzamid |
||
AP-237 |
bucinnazin; 1-X-xxxxxxx-4-xxxxxxxxxxxxxxxxxx; |
1-[4-(3-xxxxxxxxx-2-xx-1-xx)xxxxxxxxx-1-xx]xxxxx-1-xx |
|
Xxxxxxxxxxxxxxxxxxx |
XXX-X; xxxxxxxxxxxx-X |
X-xxxxx-X-[1-(2-xxxxxxxxxx)xxxxxxxxx-4-xx]-2X-1,3-xxxxxxxxxxx-5-xxxxxxxxxx |
|
Xxxxxxxxxxxxxxxxxxxxx |
X-xxxxx-X-(1-xxxxxx-xxxxxxxxx-4-xx)xxxxxxxx |
||
Xxxxxxxxxxxxxxx |
xxxxxxxxxxxxx |
X-xxxxx-X-[1-(2-xxxxxxxxxx)xxxxxxxxx-4-xx]xxxxxxxx |
|
Xxxxxxxxxxxxxx |
Xxxxxx-X; X 4129 |
X-xxxxx-X-[1-(xxxxxxxxxxx)xxxxxxxxx-4-xx]xxxxxxxxxx |
|
Xxxxxxxxxxxxxxxxxxxxx |
Xxxxxx XxX |
X-(1-xxxxxxxxxxxxxxx-4-xx)-X-xxxxxxxxxx-2-xxxxxxxxxx |
|
Xxxxxxxxxx |
X 4793e; X 47931X |
4-xxxx-X-(2-(xxxxxxxxxxxxx)xxxxxxxxxx)xxxxxxxx |
|
4-Xxxxxxxxxxxxxxxxxxxxx |
4-Xx-xXX |
X-(4-xxxxxxxxxx)-2-xxxxxx-X-[1-(2-xxxxxxxxxx)-4-xxxxxxxxxxx]xxxxxxxxxx |
|
Xxxxxxxxxxxxxxxxxxx |
Xxxxxxxxxxx-X; XX-X |
X-xxxxx-X-[1-(2-xxxxxxxxxx)xxxxxxxxx-4-xx]xxxxxxxxxxxxxxxxxxxxx |
|
Xxxxxxxxxxxxxxxxxxx |
X-xxxxx-X-[1-(2-xxxxxxxxxx)xxxxxxxxx-4-xx]xxxxxxxxxxxxxxxxxxxxx |
||
Xxxxxxxxxx |
4,5α-xxxxx-17-xxxxxxxxxxxxxx-3-xx |
||
Xxxxxxxxxxxx-2-xxxxx xxxxxxxx |
X-(2-xxxxxxxxxx)-1-(2-xxxxxxxxxx)xxxxxxxxx-4-xxxx |
||
Xxxxxxxxxxxx-4-xxxxx xxxxxxxx |
X-(4-xxxxxxxxxx)-1-(2-xxxxxxxxxx)xxxxxxxxx-4-xxxx |
||
Xxxxxxx |
(5X, 6X, 7X, 14X)-4,5-xxxxx-7-[(2X)-2-xxxxxxxxxxxxx-2-xx]-6-xxxxxxx-17-xxxxxx-6,14-xxxxxxxxxxxxx-3-xx |
||
Xxxxxxxx xxxxxxxxx xxxxxx |
Xxxxxxxxxxxxx |
X-xxxxx-X-[1-(2-xxxxxxxxxx)-4-xxxxxxxxxxx]-xxxxxxxxx |
|
3-Xxxxxxxxxxxxxxxxxxxxxx |
β'-xxxxxxxxxxxxx |
X-xxxxx-X-[1-(2-xxxxxxxxxx)xxxxxxxxx-4-xx]-3-xxxxxxxxxxxxxxx |
xxxxxxxxxxxxxxxxxxxxxx |
4-Xxxxx-xxxxxxxxxxxxx |
4X-XX |
X-(4-xxxxxxxxxx)-X-[(1-(2-xxxxxxxxxx)-4-xxxxxxxxxxx)]xxxxxxxxx |
|
4-Xxxxx-xxxxxxxxxxxxxxxxxxxxxxxxx |
xxxx-xxxxxxxxxxxxxxxxxxxxxx-xxxxxxxx |
X-(4-xxxxxxxxxx)-X-(1-xxxxxxxxxxxxxxx-4-xx)-xxxxxxxxxxxxxxxxxxxxx |
|
2-Xxxxxxxxxxxxx |
Xxxxxxxxxxxxxxxxx |
X-(2-xxxxxxxxxx)-X-[1-(2-xxxxxxxxxx)-4-xxxxxxxxxxx]xxxxxxxxxx |
2-XX, x-XX |
3-Xxxxxxxxxxxxx |
Xxxxxxxxxxxxxxxxx |
X-(3-xxxxxxxxxx)-X-[1-(2-xxxxxxxxxx)-4-xxxxxxxxxxx]xxxxxxxxxx |
3-XX, x-XX |
4-Xxxxxxxxxxxxxxxxxxxx |
xxxx-xxxxxxxxxxxxxxxxxxxx; 4X-xxxxxxx xxxxxxxx |
X-(4-xxxxxxxxxx)-X-(1-xxxxxxxxxxxxxxxxx-4-xx)xxxxx-2-xxxxxxxxxx |
|
4-Xxxxxxxxxxxxxxxxxxxxx |
4X-xXX |
X-(4-xxxxxxxxxx)-2-xxxxxx-X-[1-(2-xxxxxxxxxx)-4-xxxxxxxxxxx]xxxxxxxxxx |
|
3-Xxxxxxxxxxxxxxxxxxxxxxxxxx |
xxxxx-xxxxxxxxxxxxxxxxxx-xxxxxxxx |
X-(3-xxxxxxxxxx)-2-xxxxxxx-X-[1-(2-xxxxxxxxxx)xxxxxxxxx-4-xx]xxxxxxxx |
|
Xxxxxxxxxxxxxxx |
XX-X; 2-furanoylfentanyl |
N-fenyl-N-[1-(2-fenylethyl)piperidin-4-yl]-furan-24íarboxamid |
|
(iso)Butyryl-F-fentanyl X-xxxxxx analog |
N-(1-benzylpiperidin-4-yl)-N-(4-fluorfenyl)butanamid |
||
Heroin |
(5R,6S)-4,5-epoxy-17-methylmorfin-7-en-3,6-diyl-diacetát |
||
4-hydroxybutyrfentanyl |
4-HO-BF; para-hydroxybutyrylfentanyl |
N-(4-hydroxyfenyl)-N-[1-(2-fenylethyl)piperidin-4-yl]-butanamid |
|
Isopropyl-U-47700 |
3,4-dichlor-N-[2-(dimethylamino)cyklohexyl]-N-(propan-2-yl)benzamid |
||
Isotonitazen |
N,N-diethvl-2-[[4-(1-methylethoxy)fenyl]methyl]-5-nitro-1H-benzimidazol-1-ethanamin |
||
Ketobemidon |
1-[4-(3-hydroxyfenyl)-1-methylpiperidin-4-yl]propan-1-on |
||
Konopí |
S xxxxxxxx xxxxxx xxx 1 léčebné xxxxxxx xxxxxxx v xxxxxxx x. 1 |
||
Xxxxxxxxxxxxxxxx |
(2X)-X-xxxxx-X-[1-(2-xxxxxxxxxx)xxxxxxxx-4-xx]-2-xxxxxxxxx |
||
Xxxxxxxxxxxxxxxxxxxxx |
Xxxxxxx-XxX |
2-xxxxxxx-X-xxxxx-X-x 1-(2-fenylethyl)piperidin-4-yl]acetamid |
|
4-Methoxybutyr xxxxxxxx |
4-XxX-XX |
X-(4-xxxxxxxxxxxx)-X-[ 1-(2-xxxxxxxxxx)xxxxxxxxx-4-xx]xxxxxxxxx |
|
2-xxxxxxxxxxxxxxxxxxxx |
x-xxxxxxxxxxxxxxxxxxxx |
X-(2-xxxxxxxxxxx)-X-[1-(2-xxxxxxxxxx)-xxxxxxxxx-4-xx]-xxxxxxxx |
|
2-xxxxxx-XX-237 |
2-xxxxxx-xxxxxxxxxx |
1-[2-xxxxxx-4-(3-xxxxxxxxx-2-xx-1-xx)xxxxxxxxx-1-xx]xxxxx-1-xx |
|
3,4-xxxxxxxxxxxxx-X-47700 |
3,4-XXX-X-47700; |
X-(2-(xxxxxxxxxxxxx)xxxxxxxxxx)-X-xxxxxxxxxxx[x][1,3]xxxxxx-5-xxxxxxxxxx |
|
α-Xxxxxxxxxxxxxx xxxxxxxxx analog |
BF; X-X |
2-xxxxxx-X-xxxxx-X-[1-(1-xxxxxxxxxxx-2-xx)xxxxxxxxx-4-xx]xxxxxxxxxx |
|
3-xxxxxxxxxxxxxxxxxxxxxx |
β'-xxxxxxxxxxxxxxxxxxxxxx |
X-xxxxx-X-[1-(2-xxxxxxxxxx)-xxxxxxxxx-4-xx]-3-xxxxxxxxx-2-xxxxxx |
|
XX-45 |
1-xxxxxxxxxx-4-(1,2-xxxxxxxxxxxx)xxxxxxxxx |
||
X-xxxxxx X-47931X |
X-xxxxxxxxxxxxxxxx |
4-xxxx-X-(2-(xxxxxxxxxxxxx)xxxxxxxxxx)-X-xxxxxxxxxxxxxx |
|
XXxxxxxxxx |
X-3217 |
X-(2-xxxxxxxxxx)-2-xxxxxxx-X-[1-(2-xxxxxxxxxx)xxxxxxxxx-4-xx]xxxxxxxx |
|
Xxxxxxxxxxxxxxxxxxx |
xxxxxxxxxxxxx, PBN, 127C49 |
1-(4,4-di(thiofen-2-yl)but-3-en-2-yl)pipendin |
|
Pryskyřice x konopí |
|||
Tetrahydrofuranfentanyl |
THF-F |
N-(1-fenylethylpiperidin-4-yl)-N-fenyltetrahydrofuran-2-karboxamid |
|
Tetramethylcyklopropanfentanyl |
TMCP-fentanyl; TMCP-F |
N-fenyl-N-f 1-(2-xxxxxxxxxx)xxxxxxxxx-4-xx]-2,2,3,3-xxxxxxxxxxxxxxxxxxxxxx-1-xxxxxxxxxx |
|
Xxxxxxxxxxxxxxx |
2-xxxxxxxxxxx xxxxxxxx |
X-(1-xxxxxxxxxxxxxxxxx-4-xx)-X-xxxxxxxxxxxx-2-xxxxxxxxxx |
|
X-47700 |
3,4-xxxxxxx-X-[2-(xxxxxxxxxxxxx)xxxxxxxxxx]-X-xxxxxxxxxxxxxx |
||
X-48800 |
2-(2,4-xxxxxxxxxxxx)-X-(2-(xxxxxxxxxxxxx)xxxxxxxxxx)-X-xxxxxxxxxxxxxx |
||
X-49900 |
3,4-xxxxxxx-X-[2-(xxxxxxxxxxxx)xxxxxxxxxx]-X-xxxxxxxxxxxxxx |
||
X-50488 |
3,4-xxxxxxx-X-xxxxxx-X-[2-(1-xxxxxxxxxxxx)xxxxxxxxxx] xxxxxxxxxxxxxx |
||
X-51754 |
2-(3,4-xxxxxxxxxxxx)-X-[2-(xxxxxxxxxxxxx)xxxxxxxxxx]-X-xxxxxxxxxxxxxx |
||
Xxxxxxxxxxxxxxx |
XXX, XX |
X-xxxxx-X-[1-(2-xxxxxxxxxx)-4-xxxxxxxxx]xxxxxxxxxx; xxxxxxxx xxxxxxxxxx xxxxxx |
Xxxxxx xxxx xxxxxxxx xxxxx xxxxxxxxx x&xxxx;xxxxx xxxxxxx xx xxxxx xxxxxxxxx, xxx xxxx xxxx xxxxx existovat.
Xxxxxxx x. 4 x xxxxxxxx vlády x. 463/2013 Xx.
Xxxxxx x. 4 xxxxxxxxxxxxxx xxxxx
Xxxxxxxxxxx xxxxxxxxxx xxxxx (XXX) v xxxxxx xxxxxx / xxxxxx xxxxx |
Xxxxx xxxxxxxxxxx xxxxxxxxxx xxxxx xxxx xxxxx xxxxxx xxxxx |
Xxxxxxxx xxxxx xxxxx XXXXX |
Xxxxxxxx |
XX-XXXXXXXX |
X-[(1X)-1-(xxxxxxxxxxxxx)-2-xxxxxxxxxxxx]-1(xxxxxxxxxxxxxxxx)-1X-xxxxxxx-3-xxxxxx-xxxx |
||
XX-XXXXXXXX |
X-(1-xxxxx-3-xxxxxx-1-xxxxxxxx-2-xx)-1-(4-xxxxxxxxxxx)-1X-xxxxxxx-3-xxxxxxxxxx |
||
XX-XXXXXX |
X-[(1,X)-1-(xxxxxxxxxxxxx)-2-xxxxxxxxxxxx]-1-xxxxxx-1X-xxxxxxx-3-xxxxxxxxxx |
||
4-Xxxxxxx-X-xxxxxx-X-xxxxxxxxxxxxxx |
4-XxX-XXX |
{3-[2-(xxxxxxxxxxxxxxxx)xxxxx]-1X-xxxxx-4-xx}xxxxxx |
|
x-Xxxxxxxxxxxxxx |
4-XxX-XXX |
{3-[2-(xxxxxxxxxxxxx)xxxxx]-1X-xxxxx-4-xx}xxxxxx |
Xxxxxxxxxx |
XXX-XXXXXXXX |
X-[1-(xxxxxxxxxxxxx)-2,2-xxxxxxxxxxxxxx]-1-(xxxxxxxxxxxxxxxx)-1X-xxxxxxx-3-xxxxxxxxxx |
||
XXX-XXXXXXXX |
X-(1-xxxxx-3,3-xxxxxxxx-1-xxxxxxxx-2-xx)-1-[(4-xxxxxxxxxx)xxxxxx]xxxxxxx-3-xxxxxxxxxx |
||
XXX-XXXXXX |
X-(1-xxxxx-3,3-xxxxxxxx-1-xxxxxxxx-2-xx)-1-xxxxxx-1X- xxxxxxx-3-xxxxxxxxxx |
||
XX-XXX |
(6xX,9X)-7-xxxxx-X,X-xxxxxxx-6,6x,8,9-xxxxxxxxxx-4X-xxxxx[4,3-xx]xxxxxxxx-9-xxxxxxxxxx |
6-xxxxx-6-xxx-XXX |
|
XX-2201 |
[1-(5-xxxxxxxxxxx)-1X-xxxxx-3-xx] (xxxxxxxx-1-xx)xxxxxxxx |
||
XXX-XXXXXXXX |
XXX-XXX |
Xxxxxx 2-({1-[(4-fluorfenyl)methyl]-1H-indazol-3-karbonyl}amino)-3-methylbutanoát |
MMB-FUBINACA |
AMB-CHMICA |
Methyl (2S)-2-{[1-(cyklohexylmethyl)indol-3-karbonyl]amino}-3-methylbutanoát |
||
5-Aminopropylindol |
5-API |
5-(2-aminopropyl)indol |
|
APICA |
SDB-001, 2XX1 |
X-(xxxxxxxxx-1-xx)-1-xxxxxx-1X-xxxxx-3-xxxxxxxxxx |
|
XXXXXXX |
X-(xxxxxxxxx-1-xx)-1-xxxxxx-1X-xxxxxxx-3-xxxxxxxxxx |
XXX48 |
|
xx-XXX |
2-xxxxx-1-(4-xxxxxxxxxxxx)xxxxxx-1-xx |
||
Xxxxxxxxx |
xx-XXXX |
1-(4-xxxxxxxxxxxx)-2-(xxxxxxxxxxx)xxxxxx-1-xx |
|
XXXX |
3,4-XXXX |
2-xxxxxxxxxxx-1-(3,4-xxxxxxxxxxxxxxxxxx)xxxxxx-1-xx |
|
2-Xxxxxxxxxxxxxxxx |
2-XXX |
(XX)-1-(2-xxxxxxxxx)-2-(xxxxxxxxxxx)xxxxxx-1-xx |
|
3-Xxxxxxxxxxxxxxxx |
3-XXX |
(XX)-1-(3-xxxxxxxxx)-2-(xxxxxxxxxxx)xxxxxx-1-xx |
|
4-Xxxxxxxxxxxxxxxx |
4-XXX |
(XX)-1-(4-xxxxxxxxx)-2-(xxxxxxxxxxx)xxxxxx-1-xx |
Xxxxxxxxx |
25X-XXXXx |
2-(4-xxxx-2,5-xxxxxxxxxxxxxx)-X-[(2-xxxxxxxxxxxx)xxxxxx]xxxxxxxxx |
Xxxxx-36 |
|
25X-XXXXx |
2-(4-xxxxx-2,5-xxxxxxxxxxxxxx)-X-[(2-xxxxxxxxxxxx)xxxxxx]xxxxxxxxx |
2X-X-XXXXx |
|
25X-XXX; 25X-XX2X; 2X-X-XXX, XXX-2X-X; Xxxxx-21 |
2-(4-xxx-2,5-xxxxxxxxxxxxxx)-X-[(2-xxxxxxxxxx)xxxxxx]xxxxxxxxx |
||
25X-XXXX |
2-{[2-(4-xxx-2,5-xxxxxxxxxxxxxx)xxxxxxxxxx]xxxxxx}xxxxx |
2X-X-XXXX; Cimbi-27 |
|
25I-NBOMe |
2-(4-jod-2,5-dimethoxyfenyl)-N-[(2-methoxyfenyl)methyl]ethanamin |
NBOMe-2C-I |
|
Bromo-Dragonfly |
(2R)-1-(4-bromfuro[2,3-f] [1]xxxxxxxxxx-8-xx)xxxxxx-2-xxxx |
||
Xxxxxxx |
Xx-XXXX |
2-(xxxxxxxxxxx)-1-[3,4-(xxxxxxxxxxxxx)xxxxx]xxxxx-1-xx |
Xx |
2-Xxxxxxxxxxxxxx |
2-XX |
1-(2-xxxxxxxxxx)xxxxxx-2-xxxx |
|
3-Xxxxxxxxxxxxxx |
3-XX |
1-(3-xxxxxxxxxx)xxxxxx-2-xxxx |
|
4-Xxxxxxxxxxxxxx |
4-XX |
1-(4-xxxxxxxxxx)xxxxxx-2-xxxx |
XXX |
4-Xxxxx-X-xxxxxxxxxxxxx |
4-XXX |
2-(xxxxxxxxxx)-1-(4-xxxxxxxxxx)xxxxxx-1-xx |
4-Xxxxxxxxxxxxxxxxxx |
2-Xxxxxxxxxxxxxxxx |
2-XXX |
1-(2-xxxxxxxxx x)-2-(xxxxxxxxxx)xxxxxx-1-xx |
|
3-Xxxxxxxxxxxxxxxx |
3-XXX |
1-(3-xxxxxxxxx x)-2-(xxxxxxxxxx)xxxxxx-1-xx |
|
4-Xxxxxxxxxxxxxxxx |
4-XXX |
1-(4-xxxxxxxxx x)-2-(xxxxxxxxxx)xxxxxx-1-xx |
|
2X-X |
2-(4-xxxxx-2,5-xxxxxxxxxxxxxx)xxxxx-1-xxxx |
||
2-Xxxxxxxxxxxxxxxxxx |
2-XXX |
1-(2-xxxxxxxxxx)-X-xxxxxxxxxxxx-2-xxxx |
|
3-Xxxxxxxxxxxxxxxxxx |
3-XXX |
1-(3-xxxxxxxxxx)-X-xxxxxxxxxxxx-2-xxxx |
|
4-Xxxxxxxxxxxxxxxxxx |
4-XXX |
1-(4-xxxxxxxxxx)-X-xxxxxxxxxxxx-2-xxxx |
x-XXX |
2-Xxxxxxxxxxxxxxxxx |
2-XXX |
1-(2-xxxxxxxxxx)-2-(xxxxxxxxxxx)xxxxxx-1-xx |
|
3-Xxxxxxxxxxxxxxxxx |
3-XXX |
1-(3-xxxxxxxxxx)-2-(xxxxxxxxxxx)xxxxxx-1-xx |
|
4-Xxxxxxxxxxxxxxxxx |
4-XXX |
1-(4-xxxxxxxxxx)-2-(xxxxxxxxxxx)xxxxxx-1-xx |
Xxxxxxxxx |
2-Xxxxxxxxxxxxxx |
2-XXX |
1-(2-xxxxxxxxxx)-2-(xxxxxxxxxxx)xxxxxx-1-xx |
|
3-Xxxxxxxxxxxxxx |
3-XXX |
1-(3-xxxxxxxxxx)-2-(xxxxxxxxxxx)xxxxxx-1-xx |
|
4-Xxxxxxxxxxxxxx |
4-XXX |
1-(4-xxxxxxxxxx)-2-(xxxxxxxxxxx)xxxxxx-1-xx |
|
4-Xxxxx-α-xxxxxxxxxxxxxxxxxxxxxx |
4-Xx-α-XXX |
1-(4-xxxxxxxxxx)-2-(xxxxxxxxxx-1-xx)xxxxxx-1-xx |
|
XXXXX-4XX-XXXXXX |
XXX-78 |
1-(4-xxxxxxxxxx)-X-(1-xxxxxx-1-xxxxxxxxxx)xxxxxxx-3-xxxxxxxxxx |
|
Xxxxxxxxxxxxxxxxxxxxxxxxxxxxxx |
2X-X-2 |
[4-(xxxxxxxxxxxxx)-2,5-xxxxxxxxxxxxxxxxx]xxxx |
|
Xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx |
2X-X-7 |
[4-(xxxxxxxxxxxxxx)-2,5-xxxxxxxxxxxxxxxxx]xxxx |
|
XX-47,497 |
2-[(1X,3X)-3-xxxxxxxxxxxxxxxxx]-5-(2-xxxxxxxxxxx-2-xx)xxxxx |
||
XXX-13 |
(xxxxxxxx-1-xx)[4-(xxxxxxxxx)xxxxxxxx-1-xx]xxxxxxxx |
XX-13 |
|
XXXX |
1,4-xxxxxxxxxxxxxxxxx |
||
Xxxxxxxxxxxxxxx |
2-(xxxxxxxxxxx)-2-xxxxxxxxxxxxxxx-1-xx |
||
Xxxxxxxx-X-xxxxx-xxxxxxx |
X-XXX; 2-Xxx-XXX, xxxxxxxxxxxx |
2-(xxxxxxxxxx)-2-xxxxxxxxxxxxxxx-1-xx |
|
Xxxxxxxxx |
Xx-XXXXX |
1-(1,3-xxxxxxxxxxx-5-xx)-2-(xxxxxxxxxxxxx)-1-xxxxxxx |
Xxxxxxxxxxxxx X |
Xxxxxxxxxx |
2-xxxxxxxxxxxxxx |
7-xxxxx-5-(2-xxxxxxxxxx)-1-xxxxxx-1,3-xxxxxxx-2X-1,4-xxxxxxxxxxxxx-2-xx |
Xx 5-3448 |
Xxxxxxxxxxxxxxxx |
XXX |
X,X-xxxxxxx-X-[2-(xxxxx-3-xx)xxxxx]xxxx |
|
Xxxxxxxxx |
XXX; 1,2-DEP; XXXX |
1-(1,2-xxxxxxxxxxxx)xxxxxxxxx |
XX1X4X21 |
5-Xxxxxxxxxxxxxxxxxxxxxxxxxxxx |
5-XXXXX; MBPV |
1-(2,3-dihydrobenzofuran-5-yl)-2-(pyrrolidin-1-yl)pentan-1-on |
|
3,4-Dichlormethylfenidát |
3,4-CTMP |
methyl (2R)-2-(3,4-dichlorfenyl)-2-[(2R)-piperidin-2-yl]acetát |
|
Dimethoxyamfetamin |
DMA |
(2RS)-1-(2,5-dimethoxyfenyl)propan-2-amin |
|
p-Methyl-4-methylaminorex |
4,4'-DMAR |
4-methyl-5-(4-methylfenyl)-4,5-dihydro-1,3-oxazol-2-amin |
p4-DMAR |
Dimethylheptyltetrahydrokanabinol |
DMHP |
3-(1,2-dimethylheptyl)-6,6,9-trimethyl-7,8,9,10-tetrahydro-6H-benzo[c]chromen-1-ol |
|
2,3-Dimethylmetkathinon |
2,3-DMMC |
1-(2,3-dimethylfenyl)-2-(methylamino)propan-1-on |
|
2,4-Dimethylmetkathinon |
2,4-DMMC |
1-(2,4-dimethylfenyl)-2-(methylamino)propan-1-on |
|
3,4-Dimethylmetkathinon |
3,4-DMMC |
1-(3,4-dimethylfenyl)-2-(methylamino)propan-1-on |
|
Dimethyltriptamin |
DMT |
N-[2-(indol-3-yl)ethyl]-N,N-dimethylamin |
|
Brolamfetamin |
DOB |
(2RS)-1-(4-brom-2,5-dimethoxyfenyl)propan-2-amin |
|
2,5-Dimethoxy-4-chloramfetamin |
DOC |
1-(4-chlor-2,5-dimethoxyfenyl)propan-2-amin |
|
Dimethoxyethylamfetamin |
DOET |
(2RS)-1-(4-ethyl-2,5-dimethoxyfenyl)propan-2-amin |
|
Dimethoxymetamfetamin |
STP, XXX |
(2XX)-1-(2,5-xxxxxxxxx-4-xxxxxxxxxxx)xxxxxx-2-xxxx |
|
2,5-Xxxxxxxxx-4-xxxxxxxxxxxx |
XXX |
1-(4-xxx-2,5-xxxxxxxxxxxxxx)xxxxxx-2-xxxx |
|
5-XXXX |
1-(1-xxxxxxxxxx-5-xx)-X-xxxxxxxxxxx-2-xxxx |
||
6-XXXX |
1-(1-xxxxxxxxxx-6-xx)-X-xxxxxxxxxxx-2-xxxx |
||
Xxxxxxxxxx |
Xx-XXXXX |
1-(1,3-xxxxxxxxxxx-5-xx)-2-(xxxxxxxxxxxxx)xxxxxx-1-xx |
3,4-xxxxxxxxxxxxxxx- xxxxxxxxxxxxxx |
Xxxxxxxxxxxx |
Xxxxxxx |
(2XX)-1-xxxxx-2-(xxxxxxxxxxx)xxxxxx-1-xx |
|
Xxxxxxxx |
XXXXX; xxxxxxxxxx; XXX |
X-xxxxx-1,2-xxxxxxxxxxxxxxxx |
|
Xxxxxxx |
XXXXX; xx-XXXX |
1-(xxxxx[x] [1,3]xxxxxx-5-xx)-2-(xxxxxxxxxx)xxxxxx-1-xx |
X-xxxxx-xxxxxxxx |
XXX-XXX |
(6xX,9X)-X,X-xxxxxxx-7-xxxxx-4,6,6x,7,8,9-xxxxxxxxxxxxxx-[4,3-xx]xxxxxxxx-9-xxxxxxxxxx |
||
Xxxxxxxx |
XXX 3219; Xxxxx |
4-(2-xxxxxxxxxx)-2-xxxxx-9-xxxxxx-6X-xxxxxx[3,2-x][1,2,4]xxxxxxxx[4,3-x][1,4]xxxxxxxx |
|
4’-xxxxx-α-XXX |
4'-xxxxx-α-xxxxxxxxxxxxxxxxxxxxxx |
1-(4-xxxxxxxxxx)-2-(xxxxxxxxxx-1-xx)xxxxxx-1-xx |
|
Xxxxxxxxxxxx |
(X,X)-xxxxx-2-xxxxx-2-xxxxxxxxx-2-xxxxxxxx |
||
X-xxxxxxxxxxxxxx |
Xxxxxxxxxxxxxxx |
2-(xxxxxxxxxx)-1-xxxxx-xxxxxx-1-xx |
|
X-xxxxxxxxxxxxx |
XXX-XX; Xxxxxxxxxxxxxx; Xxxxx-Xxx |
2-(xxxxxxxxxx)-1-xxxxx-xxxxx-1-xx |
|
2-Xxxxxxxxxxxxxxxxx |
2-XXX |
(XX)-2-xxxxxxxxxxx-1-(2-xxxxxxxxxx)xxxxxx-1-xx |
|
3-Xxxxxxxxxxxxxxxxx |
3-XXX |
(XX)-2-xxxxxxxxxxx-1-(3-xxxxxxxxxx)xxxxxx-1-xx |
|
4-Xxxxxxxxxxxxxxxxx |
4-XXX |
(XX)-2-xxxxxxxxxxx-1-(4-xxxxxxxxxx)xxxxxx-1-xx |
|
X-xxxxxxxxxxxxxxxxx |
X-xxxxxxxxxxxxxx |
2-(xxxxxxxxxx)-1-xxxxx-xxxxxx-1-xx |
α-xxxxxxxxxxxxxxxxxxxxx |
Xxxxxxxxxx |
3-(2-xxxxxxxxxx)xxxxx |
||
Xxxxxxxxxxxxx |
Xx 11-5073/000 |
8-xxxxx-6-(2-xxxxxxxxxx)-1-xxxxxx-4X-[1,2,4]xxxxxxxx[4,3-x] [1,4]xxxxxxxxxxxxx |
|
2-Xxxxxxxxxxxxxx |
2-XX |
1-(2-xxxxxxxxxx)xxxxxx-2-xxxx |
|
3-Xxxxxxxxxxxxxx |
3-XX |
1-(3-xxxxxxxxxx)xxxxxx-2-xxxx |
|
4-Xxxxxxxxxxxxxx |
4-XX |
1-(4-xxxxxxxxxx)xxxxxx-2-xxxx |
|
5X-XXXXXX |
X-(1-xxxxx-3,3-xxxxxxxx-1-xxxxxxxx-2-xx)-1-(5-xxxxxxxxxxx)-1X-xxxxx-3-xxxxxxxxxx |
||
5X-XXX48 |
X-(xxxxxxxxx-1-xx)-1-(5-xxxxxxxxxxx)-1X-xxxxxxx-3-xxxxxxxxxx |
||
5X-XXX-XXXXXX |
5X-XXX |
xxxxxx-2-({[1-(5-xxxxxxxxxxx)-1X-xxxxxxx-3-xx]xxxxxxxx}xxxxx)-3-xxxxxxxxxxxxxx |
5X-XXX |
5X-X-X7XXXX |
X-(xxxxxxxxx)-1-(5-xxxxxxxxxxxx)-1X-xxxxxxx[2,3-x]xxxxxxxx-3-xxx-xxxxxxxx |
X-(xxxxxxxxx-1-xx)-1-(5-xxxxxxxxxxx)-1X-xxxxxxx[2,3-x]xxxxxxx-3-xxxxxxxxxx |
|
5X-XXXX-XXXXXX |
xxxxx 2-{[1-(5-xxxxxxxxxxx)-1X-xxxxxxx-3-xxxxxxxx]xxxxx}-3,3-xxxxxxxxxxxxxxxx |
||
3X-Xxxxxxxxxxx |
3-XXX; PAL-593 |
2-(3-fluorofenyl)-3-methylmorfolin |
|
4F-Fenmetrazin |
4-FPM |
2-(4-fluorofenyl)-3-methylmorfolin |
|
5F-JWH-398 |
CL-2201; XXX-398 X-(5-xxxxxxxxxxx) xxxxxx |
(4-xxxxxxxxxxxxx-1-xx)[1-(5-xxxxxxxxxxx)-1X-xxxxx-3-xx]-xxxxxxxx |
|
2-Xxxxxxxxxxxxxxxxxxxx |
2-Xx-2'-Xxx-XXX, xxxxxxxxxxxxxx 2-XXXX, 2-XXX, 2-XX |
2-(2-xxxxxxxxxx)-2-xxxxxxxxxxx-xxxxxxxxxxxx |
|
3-Xxxxxxxxxxxxxxxxx |
3-xxxxxxxxxxxxxxxxxxxxxx; 3-XXX |
X-xxxxx-1-(3-xxxxxxxxxx)xxxxxx-2-xxxx; X-xxxxx-3-xxxxxxxxxxxxxx |
|
2-Xxxxxxxxxxxxxxxx |
2-XXX |
1-(2-xxxxxxxxxx)-2-(xxxxxxxxxx)xxxxxx-1-xx |
|
3-Xxxxxxxxxxxxxxxx |
3-XXX |
1-(3-xxxxxxxxxx)-2-(xxxxxxxxxx)xxxxxx-1-xx |
|
4-Xxxxxxxxxxxxxxxx |
4-XXX |
1-(4-xxxxxxxxxx)-2-(xxxxxxxxxx)xxxxxx-1-xx |
|
2-Xxxxxxxxxxxxxxxxxx |
2-XXX |
(XX)-1-(2-xxxxxxxxxx)-X-xxxxxxxxxxxx-2-xxxx |
|
3-Xxxxxxxxxxxxxxxxxx |
3-XXX |
(XX)-1-(3-xxxxxxxxxx)-X-xxxxxxxxxxxx-2-xxxx |
|
4-Xxxxxxxxxxxxxxxxxx |
4-XXX |
(XX)-1-(4-xxxxxxxxxx)-X-xxxxxxxxxxxx-2-xxxx |
|
2-Xxxxxxxxxxxxxxxxx |
2-XXX |
1-(2-xxxxxxxxxx)-2-(xxxxxxxxxxx)xxxxxx-1-xx |
|
3-Xxxxxxxxxxxxxxxxx |
3-XXX |
1-(3-xxxxxxxxxx)-2-(xxxxxxxxxxx)xxxxxx-1-xx |
|
4-Xxxxxxxxxxxxxxxxx |
4-XXX |
1-(4-xxxxxxxxxx)-2-(xxxxxxxxxxx)xxxxxx-1-xx |
Xxxxxxxxx |
4-Xxxxxxxxxxxxxxxxxx |
4X-XXX; 4-XXXX |
Xxxxxx-2-(4-xxxxxxxxxx)-2-(2-xxxxxxxxx)xxxxxx |
4X-XXX |
4-Xxxxxxxxxxxxxx |
4-XXX; 4-X-xxxxxxxxx |
1-(4-xxxxxxxxxx)-2-(xxxxxxxxxxx)xxxxxx-1-xx |
|
5X-XX-22; 5F-QUPIC |
8-chinolinyl ester xxxxxxxx 1-(5-xxxxxxxxxxx)-1X-xxxxx-3-xxxxxxxxxxx |
||
4X-XXXX-XXXX |
xxxxxx (S)-2-({[1-(4-fluorbutyl)-1H-indol-3-yl]karbonyl}amino)-3,3-dimethylbutanoát |
||
4F-MDMB-BINACA |
4F-ADB |
methyl (X)-2-({[1-(4-xxxxxxxxxx)-1X-xxxxxxx-3-xx]xxxxxxxx}xxxxx)-3,3-xxxxxxxxxxxxxxxx |
|
5X-XXXX-XXXX |
5X-XXXX-2201 |
xxxxxx (X)-2-({[1-(5-xxxxxxxxxxx)-1X-xxxxx-3-xx]xxxxxxxx}xxxxx)-3,3-xxxxxxxxxxxxxxxx |
|
5X-XXXX-XXXXXX |
5X-XXX |
xxxxxx (X)-2-({[1-(5-xxxxxxxxxxx)-1X-xxxxxxx-3-xx]xxxxxxxx}xxxxx)-3,3-xxxxxxxxxxxxxxxx |
|
5XXX-144 |
[1-(5-xxxxxxxxxxx)-1X-xxxxx-3-xx] (2,2,3,3-xxxxxxxxxxxxxxxxxxxxxx)xxxxxxxx |
XXX-11 |
|
Xxxxxxx |
βx-XXXX |
1-(1,3-xxxxxxxxxxx-5 -xx)-2-(xxxxxxxxxxx)xxxxx-1-xx |
|
4-Xxxxxxx-X-xxxxxx-X-xxxxx tryptamin |
4-HO-MET |
3-{2-[ethyl(methyl)amino]ethyl}-1H-indol-4-ol |
Metocin; Xxxxxxxxxxx |
4-Xxxxxxx-X-xxxxxx-X-xxxxxxxxx xxxxxxxxx |
4-XX-XxXX |
3-{2-[xxxxxx(xxxxxx-2-xx)xxxxx]xxxxx}-1X-xxxxx-4-xx |
Xxxxxxxx |
Xxxxxxxxxxxxxxxxxxx |
(2X,X)-X-xxxxxxx-1-[3,4-(xxxxxxxxxxxxx)xxxxx]xxxxxx-2-xxxx |
||
Xxxxxxxxxxxxxxxxxxxxxxxx |
2X-X |
(4-xxx-2,5-xxxxxxxxxxxxxxxxxxx)xxxx |
|
XXX-018 |
(xxxxxxxx-1-xx)(1-xxxxxx-1X-xxxxx-3-xx)xxxxxxxx |
||
XXX-073 |
(1-xxxxx-1X-xxxxx-3-xx)(xxxxxxxx-1-xx)xxxxxxxx |
||
XXX-081 |
(4-xxxxxxxxxxxxxxx-1-xx)(x -xxxxxx-1X-xxxxx-3-xx)xxxxxxxx |
||
XXX-122 |
(4-xxxxxxxxxxxxxx-1-xx)(1-xxxxxx-1X-xxxxx-3-xx)xxxxxxxx |
||
XXX-200 |
1-(2-xxxxxxxxxxxxxx)-1X-xxxxx-3-xx] (xxxxxxxx-1-xx)xxxxxxxx |
||
XXX-210 |
(4-xxxxxxxxxxxxx-1-xx)(1-xxxxxx-1X-xxxxx-3-xx)xxxxxxxx |
||
XXX-250 |
2-(2-xxxxxxxxxxxx)-1-(1-xxxxxx-1X-xxxxx-3-xx)xxxxx-1-xx |
||
XXX-398 |
(4-xxxxxxxxxxxxx-1-xx)(1-xxxxxx-1X-xxxxx-3-xx)xxxxxxxx |
||
Xxxxxxxx |
(2X)-2-xxxxx-1-xxxxxxxxxxx-1-xx |
||
Xxxxxxxxxx |
6-(2-xxxxxxxxxx)-1-xxxxxx-8-xxxxx-4X-[1,2,4]xxxxxxxx[4,3-x][1,4]xxxxxxxxxxxxx |
||
(+)-Xxxxxxxx |
XXX, LSD-25 |
(+)-8β-(3,3-dimethylureido)-6-methyl-9,10-didehydroergolin |
|
lp-LSD, 1X-XXX |
xxxxxxxxxxx xxxxxxxx 1-xxxxxxxxx xxxxxxxxx; (6xX,9X)-X,X-xxxxxxx-7-xxxxxx-4-xxxxxxxxx-6,6x,8,9-xxxxxxxxxxxxxxx[4,3-xx]xxxxxxxx-9-xxxxxxxxxx |
||
5-XxX-XxXX |
X-[2-(5-xxxxxxx-1X-xxxxx-3-xx)xxxxx]-X-xxxxxxxxxxxx-2-xxxx; 5-xxxxxxx-X-xxxxxx-X-xxx-xxxxxx tryptamin |
||
Methoxfenidin |
MXP |
1-[1-(2-methoxyfenyl)-2-fenylethyl]piperidin |
2-MeO-difenidin |
2-Methylamfetamin |
2-MA |
(2RS)-1-(2-methylfenyl)propan-2-amin |
|
3-Methylamfetamin |
3-MA |
(2RS)-1-(3-methylfenyl)propan-2-amin |
|
4-Methylamfetamin |
4-MA |
(2RS)-1-(4-methylfenyl)propan-2-amin |
|
2-MAPB |
1-(benzofuran-2-yl)-N-methylpropan-2-amin |
||
3-MAPB |
1-(benzofuran-3-yl)-N-methylpropan-2-amin |
||
4-MAPB |
1-(benzofuran-4-yl)-N-methylpropan-2-amin |
||
5-MAPB |
1-(benzofuran-5-yl)-N-methylpropan-2-amin |
||
6-MAPB |
1-(benzofuran-6-yl)-N-methylpropan-2-amin |
||
7-MAPB |
1-(benzofuran-7-yl)-N-methylpropan-2-amin |
||
MBZP |
1-benzyl-4-methylpiperazin |
||
2-Methyl-N,N-dimethylkathinon |
2-MDMC |
1-(2-methylfenyl)-2-(dimethylamino)propan-1-on |
|
3-Methyl-N,N-dimethylkathinon |
3-MDMC |
1-(3-methylfenyl)-2-(dimethylamino)propan-1-on |
|
4-Methyl-N,N-dimethylkathinon |
4-MDMC |
1-(4-methylfenyl)-2-(dimethylamino)propan-1-on |
|
m-Chlorfenylpiperazin |
mCPP |
1-(3-chlorfenyl)piperazin |
|
Tenamfetamin |
MDA |
(2RS)-1-[3,4-(methylendioxy)fenyl]propan-2-amin |
|
MDAI |
5,6-(methylendioxy)indan-2-amin |
||
Ethyltenamfetamin |
MDE, XXXX |
(2XX)-X-xxxxx-1-[3,4-(xxxxxxxxxxxxx)xxxxx]xxxxxx-2-xxxx |
|
Xxxxxxx |
xx-XXXX |
2-xxxxxxxxxx-1-(3,4-xxxxxxxxxxxxxxxxxx)xxxxxx-1-xx |
|
Xxxxxxxxxxxxxxxxxx |
XXXX |
(2X,X)-X-xxxxxx-1-[3,4-(xxxxxxxxxxxxx)xxxxx]xxxxxx-2-xxxx |
|
XXXX-XXXXXX |
X-[[1-(xxxxxxxxxxxxxxxx)-1X-xxxxx-3-xx]xxxxxxxx]-3-xxxxxx-xxxxx, xxxxxx xxxxx |
||
XXXX-4xx-XXXXXX |
(xxxxxx 3,3-xxxxxxxx-2-(1-(xxxx-4-xx-1-xx)-1X-xxxxxxx-3-xxxxxxxxxxx) xxxxxxxx) |
||
XXXX-XXXXXXXX |
2-[[1-[(4-xxxxxxxxxx)xxxxxx]xxxxxxx-3-xxxxxxxx]xxxxx]-3,3-xxxxxxxxxxxxxxxx |
||
XXXXX; 3,4-MDPHP |
1-(1,3-benzodioxol-5-yl)-2-(pyrrolidin-1-yl)hexan-1-on |
||
2,3-Methylendioxymethkathinon |
2,3-MDMC |
1-(1,3-benzodioxol-4-yl)-2-(methylamino)propan-1-on |
|
3,4-Methylendioxypyrovaleron |
MDPV |
1-[3,4-(methylendioxy)fenyl]-2-(pyrrolidin-1-yl)pentan-1-on |
MDPK |
2-Methylethkathinon |
2-MEC |
2-(ethylamino)-1-(2-methylfenyl)propan-1-on |
|
3-Methylethkathinon |
3-MEC |
2-(ethylamino)-1-(3-methylfenyl)propan-1-on |
|
4-Methylethkathinon |
4-MEC |
2-(ethylamino)-1-(4-methylfenyl)propan-1-on |
|
4-Methylmetkathinon |
Mefedron |
2-(methylamino)-1-(4-methylfenyl)propan-1-on |
|
5-MeO-AMT |
5 -xxxxxxx-α-xxxxxxxxxxxxxxx |
||
5-XxX-XXXX |
X-[2-(5-xxxxxxx-1X-xxxxx-3-xx)xxxxx]-X-(xxxx-2-xx-1-xx)xxxx-2-xx-1-xxxx |
||
3-Xxxxxxxxxxxxxxxxxx |
3-XxX-XXX |
1-[1-(3-xxxxxxxxxxxx)xxxxxxxxxx]xxxxxxxxx |
|
Xxxxxxxx |
3,4,5-xxxxxxxxxxxxxxxxxxxxxx |
||
Xxxxxxxxxxxx |
XXX |
2-(xxxxxxxxxx)-2-(3-xxxxxxxxxxxx)xxxxxxxxxxxx |
|
Xxxxxxxxxxxxxx |
(±)-5-xxxxx-4-xxxxxx-4,5-xxxxxxxxxxxxx-2-xxxx |
||
2-Xxxxxx-X-xxxxxxxxxxxxxxxxx |
2-XXXX |
2-(xxxxxxxxxx)-1-(2-xxxxxxxxxxx)-xxxxxx-1-xx |
|
3-Xxxxxx-X-xxxxxxxxxxxxxxxxx |
3-XXXX |
2-(xxxxxxxxxx)-1-(3-xxxxxxxxxxx)-xxxxxx-1-xx |
|
4-Xxxxxx-X-xxxxxxxxxxxxxxxxx |
4-XXXX |
2-(xxxxxxxxxx)-1-(4-xxxxxxxxxxx)-xxxxxx-1-xx |
|
Xxxxxxxx |
Xx-XXXX |
2-(xxxxxxxxxxx)-1-[3,4-(xxxxxxxxxxxxx)xxxxx]xxxxxx-1-xx |
|
2-Xxxxxxxxxxxxxxxxxx |
2-XXX |
1-(2-xxxxxxxxxxx)-X-xxxxxxxxxxxx-2-xxxx |
|
3-Xxxxxxxxxxxxxxxxxx |
3-XXX |
1-(3-xxxxxxxxxxx)-X-xxxxxxxxxxxx-2-xxxx |
|
4-Xxxxxxxxxxxxxxxxxx |
4-XXX |
1-(4-xxxxxxxxxxx)-X-xxxxxxxxxxxx-2-xxxx |
|
2-Xxxxxxxxxxxxxxxxx |
2-XXX |
2-(xxxxxxxxxxx)-1-(2-xxxxxxxxxxx)xxxxxx-1-xx |
|
3-Xxxxxxxxxxxxxxxxx |
3-XXX |
2-(xxxxxxxxxxx)-1-(3-xxxxxxxxxxx)xxxxxx-1-xx |
|
Xxxxxxxxxxxxxxxxxxx |
XXXX |
(2XX)-1-[5-xxxxxxx-3,4-(xxxxxxxxxxxxx)xxxxx]xxxxxx-2-xxxx |
|
4-XXX |
1-(4-xxxxxxxxxxx)-2-xxxxxxxxxxx-xxxxxx-1-xx |
||
Xxxxxxxxxxxxxxxxxxxxx |
XXX |
X-xxxxxx-1-(xxxxxxx-2-xx)xxxxxx-2-xxxx |
|
2-Xxxxxxxxxxxxxxxxxxx |
2-XXX |
(2XX)-1-[2-(xxxxxxxxxxxxxx)xxxxx]xxxxxx-2-xxxx |
|
3-Xxxxxxxxxxxxxxxxxxx |
3-XXX |
(2XX)-1-[3-(xxxxxxxxxxxxxx)xxxxx]xxxxxx-2-xxxx |
|
4-Xxxxxxxxxxxxxxxxxxx |
4-XXX |
(2XX)-1-[4-(xxxxxxxxxxxxxx)xxxxx]xxxxxx-2-xxxx |
|
Xxxxxxxx |
4-XXX-xXx; XXX |
(3-xxxxxxx-2-(xxxxxxxxxxx)-1-(x-xxxxx)xxxxxx-1-xx |
|
Xxxxxxxxxxxxxxxxx |
Xxxxxxx |
1-(xxxxxxxx-2-xx)-2-(xxxxxxxxxx-1-xx)xxxxxx-1-xx |
X-2482 |
X-xxxxxx-2-xxxxxxxxxx |
X-xxxxxx-2XX |
2,3-xxxxxxx-X-xxxxxx-1X-xxxxx-2-xxxx |
XX-2XX |
XX-2201, XXX-2201 |
xxxxxxxx-1-xx-1-(5-xxxxxxxxxxx)-1X-xxxxx-3-xxxxxxxxxx |
||
x-Xxxxxxxxxxxxxxxxx |
XXX |
3-{-2-[(xxxxxxxxxxxxx)xxxxxx]-1-xxxxxxxxxxxxxxxxx}xxxxx |
|
Xxxxxxxxx |
3-xxxxx-6,6,9-xxxxxxxxx-7,8,9,10-xxxxxxxxxx-6X-xxxxx[x]xxxxxxx-1-xx |
||
Xxxxxxxxxxx |
XXX |
X-xxxxx-1-xxxxxxxxxxxxxxxxxxx |
|
Xxxxxxxxx |
xxxxxxxxx |
1-xxxxx-2-(xxxxxxxxxxx)xxxxxx-1-xx |
|
Xxxxxxxx |
Xxxxxxxxxxxxxxxxxxxxxx; βx-XXXX |
(±)-1 -(1,3-xxxxxxxxxxx-5-xx)-2-(xxxxxxxxxxx)xxxxxx-1-xx |
|
x-Xxxxxxxxxxxxxxxxxxx |
xXXX |
1-(4-xxxxxxxxxx)xxxxxxxxx |
|
Xxxxxxxxxxxxxxxx |
XXX |
(2XX)-1-(4-xxxxxxxxxxxx)xxxxxx-2-xxxx |
|
Xxxxxxxxxxxxxxxxxxx |
XXXX |
1-(4-xxxxxxxxxxxx)-X-xxxxxxxxxxxx-2-xxxx |
|
Xxxxxxxxxx |
3-[2-(xxxxxxxxxxxxx)xxxxx]-1X-xxxxx-4-xx-xxxxxxxxxxxxxxxx |
||
Xxxxxxxx |
Xxxxxxxxx |
3-[2-(xxxxxxxxxxxxx)xxxxx]-1X-xxxxx-4-xx |
|
XX8, α-XXXX |
1-xxxxx-2-(xxxxxxxxxx-1-xx)-1-xxxxxx-1-xx |
||
XX9, α-XXX |
1-xxxxx-2-(xxxxxxxxxx-1-xx)-1-xxxxx-1-xx |
||
α-XXX |
1-xxxxx-2-(xxxxxxxxxx-1-xx)-1-xxxxxx-1-xx |
||
α-XXX |
2-(xxxxxxxxxx-1-xx)-1-(xxxxxxx-2-xx)xxxxxx-1-xx |
||
α-Xxxxxxxxxxxxxxxxxxxxxx |
α-XXX |
1-xxxxx-2-(xxxxxxxxxx-1-xx)-1-xxxxx-1-xx |
|
α-Xxxxxxxxxxxxxxxxxxxxxxxxx |
α-XxXX |
1-xxxxx-4-xxxxxx-2-(xxxxxxxxxx-1-xx)-1-xxxxxx-1-xx |
|
Xxxxxxxxxxxx |
XXX, XXXX |
1-(1-xxxxxxxxxxxxxxx)xxxxxxxxxx |
|
Xxxxxxxxxx X |
Xxxxxxxxxx X |
xxxxx1-(2XX,4xX,6xX,7X,9XX,10xXX,10xX)-9-xxxxxxx-2-(xxxxx-3-xx)-6x,10x-xxxxxxxx-4,10-xxxxxxxxxxxxxxxx-1X-xxxxx[ƒ]xxxxxxxxxx-7-xxxxxxxxxx |
|
Xxxxxxxxxxxx |
XXX |
1-[1-(2-xxxxxxx)xxxxxxxxxx]xxxxxxxxx |
|
1-(3-Xxxxxxxxxxxxxxxxxxx)xxxxxxxxx |
XXXXX |
1-[3-(xxxxxxxxxxxxxx)xxxxx]xxxxxxxxx |
|
Xxxxxxxxxxxxxxxxxxx |
XXX |
Δ6x(10x)-, Δ6x(7)-, Δ7-, Δ8-, Δ10-, Δ9(11)-xxxxxxxxxxxxxxxxxxxx x jejich xxxxxxxxxxxxx |
|
XXX-2201 |
5X-XXX-018-X, 5X-XXX-018, XX-2201 indazol xxxxxx |
[1-(5 -xxxxxxxxxxx)-1X-xxxxxxx-3-xx] (1-xxxxxx)xxxxxxxx |
|
XX-XXX |
2-(xxxxxxxxxx-1-xx)-1-(5,6,7,8-xxxxxxxxxxxxxxxxxx-2-xx)xxxxxx-1-xx |
||
Xxxxxxxxxxxxxxxxxxx |
XXX |
(2XX)-1-(3,4,5-xxxxxxxxxxxxxxx)xxxxxx-2-xxxx |
|
Xxxxxxxxxxxxxxxxxxx-2 |
XXX-2 |
(2XX)-1-(2,4,5-xxxxxxxxxxxxxxx)xxxxxx-2-xxxx |
|
2,4,6-Xxxxxxxxxxxxxxxxxxx |
XXX-6 |
1-(2,4,6-xxxxxxxxxxxxxxx)xxxxxx-2-xxxx |
|
XX-144 |
(1-xxxxxx-1X-xxxxx-3-xx)-(2,2,3,3-xxxxxxxxxxxxxxxxxxxxxx)xxxxxxxx |
XXXX-018 |
|
X-15 |
4-xxxxx-X-(1-xxxxxxxxxxxxxxxxx-2-xxxxxx)xxxxxxxxxxxxxxxx |
||
X-18 |
4-xxxxx-X-(1-[2-(4-xxxxxxxxxx)xxxxx]-xxxxxxxxx-2-xxxxxx)xxxxxxxxxxxxxxxx |
Xxxxxx xxxxxxxxxxxxx xxxxxxxxxxxxxx látek, xx xx výslovné xxxxxxx, xxxxxxxxx x&xxxx;xxxxx xxxxxxx ve xxxxx xxxxxxxxx, xxx toto xxxxxxxxxxxxx xxxxx xxxxxxxxx xxxxx zvláštního xxxxxxxxxx xxxxxxxx x xxxx xxxxxxxxxxxxxx xxxxx uvedených x&xxxx;xxxxx seznamu xx xxxxx xxxxxxxxx, xxx xxxx xxxx mohou xxxxxxxxx.
Xxxxxxx č. 5 x xxxxxxxx xxxxx x. 463/2013 Xx.
Xxxxxx x. 5 xxxxxxxxxxxxxx xxxxx
Xxxxxxxxxxx nechráněný název (XXX) v xxxxxx xxxxxx |
Xxxxx xxxxxxxxxxx nechráněný xxxxx xxxx xxxxxx xxxxx |
Xxxxxxxx xxxxx podle XXXXX |
Xxxxxxxx |
Xxxxxxxxx |
(2XX)-1-xxxxxxxxxxx-2-xxxx |
||
Xxxxxxxxxx |
xxxxxxxx 7-[(10,11-dihydro-5H-dibenzo[a,d][7]annulen-5-yl) xxxxx]xxxxxxxxx |
||
Xxxxxxxxxx |
(2X)-2-[(5X,6X,7X,14X)-17-(xxxxxxxxxxxxxxxxx)-4,5α-xxxxx-3- xxxxxxx-6-xxxxxxx-6α,14-xxxxxxxxxxxxxx-7x-xx]-3,3-xxxxxxxx xxxxx-2-xx |
||
Xxxxxxxxxxxxxxxxxxxxx xxxx |
2X-X |
(4-xxxx-2,5-xxxxxxxxxxxxxxxxx)xxxx |
|
Xxxxxxxxxxxx |
(2X)-1-xxxxxxxxxxx-2-xxxx |
||
Xxxxxxxxxxx |
XXX |
1-(1-xxxxxxxxxxxxxxx)xxxxxxxxx |
|
Xxxxxxxxx |
7-(2-{[(2XX)-1-xxxxxxxxxxx-2-xx]xxxxx}xxxxx)-1,3-xxxxxxxx-7X- xxxxx-2,6-xxxx |
||
Xxxxxxxxxxx |
2-xxxxX-3-xxxxxxxxxxxxxx |
||
Xxxxxxxxx | 1-xxxxx-2-xxxxxxxxx-xxx-2-xxxx | ||
Xxxxxxxxxxxxx |
5-(2-xxxxxxxxxx)-1-xxxxxx-7-xxxxx-1X-1,4-xxxxxxxxxxxxx-2(3X)-xx |
||
XXX |
xxxxxxxx 4-xxxxxxxxxxxxxxx |
||
Xxxxxxxxxxxx |
(2XX)-1-xxxxxxxxxxx-2-xxxx |
||
Xxxxxxxxxxxxxxx |
(2XX)-1-xxxxx-X-xxxxxxxxxxxx-2-xxxx |
||
Xxxxxxxxxxxxxxx | (2X)-2,6-xxxxxxx-X-[(2X)-1-xxxxxxxxxxx-2-xx]xxxxxxxxx | ||
Xxxxxxxxxxx |
3-(2-xxxxxxxxxx)-2-xxxxxx-1,2-xxxxxxxxxxxxxxxxx-4(3X)-xx |
||
Xxxxxxxxxx |
2-xxxxxxx-3-(2-xxxxxxxxxxx)-1,2-xxxxxxxxxxxxxxxxx-4(3X)-xx |
||
Xxxxxxxxxxxx |
(2X)-1-xxxxx-X-xxxxxxxxxxxx-2-xxxx |
||
Xxxxxxxxxxxx xxxxxxxxx |
(2XX)-1-xxxxx-X-xxxxxxxxxxxx-2-xxxx |
||
Xxxxxxxxxxxxx |
xxxxxx-(2XX)-2-xxxxx-2-[(2XX)-xxxxxxxxx-2-xx]xxxxxx |
||
Xxxxxxxxxxxx |
xxxxxxxx 5-xxxxx-5-(1-xxxxxxxxxxx)xxxxxxxxxxx |
||
Xxxxxxxxxx |
xxxxx-9-XXX |
Δ9-xxxxxxxxxxxxxxxxxxx (XXX) x xxxx xxxxxxxxxxxxx |
xxxx. (-)-xxxxx-Δ9-XXX |
Xxxxxxxx |
(2XX)-1-xxxxx-1-xxxxxxx-3-[4-(2-xxxxxxxxxxxxxxx)xxxxxxxxx-1-xx] xxxxxx-2xx |
Xxxxxx solí xxxxx xxxxxxxxx x xxxx xxxxxxx xx xxxxx xxxxxxxxx, xxx xxxxxxxxx xxxxxxxx xxxx je xxxxx.
Příloha č. 6 x nařízení vlády x. 463/2013 Sb.
Seznam x. 6 xxxxxxxxxxxxxx xxxxx
Xxxxxxxxxxx xxxxxxxxxx xxxxx (XXX) x xxxxxx xxxxxx |
Xxxxx xxxxxxxxxxx xxxxxxxxxx xxxxx xxxx obecný xxxxx |
Xxxxxxxx xxxxx xxxxx XXXXX |
Xxxxxxxx |
Xxxxxxxxxxx |
xxxxxxxx 5-xxxxx-5-xxxxxxxxxxxxxxxxxxxx |
||
Xxxxxxxxxx |
xxxxxxxx 5-xxxxx-5-xxxxxxxxxxxxxxxxxxx |
||
Xxxxxxxxxxxxx |
xxxxxxxx 5-(1-xxxxxxxx-1-xx-1-xx)-5-xxxxxxxxxxxxxxxx |
||
Xxxxxxxxxxx |
(3XX)-3-xxxxx-3-xxxxxxxxxxxxxx-2,6-xxxx |
||
Xxxxxx |
(+)-xxxxxxxxxxxxxxxx |
(1X,2X)-2-xxxxx-1-xxxxxxxxxxx-1-xx |
|
Xxxxxxxxxxx |
(2X,6X,11X)-6,11-xxxxxxxx-3-(3-xxxxxxxxx-2-xx-1-xx)-1,2,3,4,5,6- xxxxxxxxx-2,6-xxxxxxx-3-xxxxxxxxxx-8-xx |
||
Xxxxxxxxxxxxx |
xxxxxxxx 5-ethyl-5[(1RS)-1-methylbutyl]barbiturorá |
Včetně xxxx xxxxx xxxxxxxxx x xxxx skupině xx xxxxx xxxxxxxxx, xxx existence takových xxxx xx xxxxx.
Xxxxxxx x. 7 x nařízení xxxxx x. 463/2013 Sb.
Seznam x. 7 xxxxxxxxxxxxxx xxxxx
Xxxxxxxxxxx xxxxxxxxxx xxxxx (XXX) x českém xxxxxx |
Xxxxx xxxxxxxxxxx xxxxxxxxxx xxxxx xxxx xxxxxx xxxxx |
Xxxxxxxx xxxxx xxxxx XXXXX |
Xxxxxxxx |
Xxxxxxxxxxxx |
5,5-xxxxxxxxxxxxxxxxxx xxxxxxxx |
||
Xxxxxxxxxx |
8-xxxxx-6-xxxxx-1-xxxxxx-4X-[1,2,4]xxxxxxxx[4,3-x][1,4]xxxxxxxxxxxxx |
||
Xxxxxxxxxx |
2-(xxxxxxxxxxxx)-1-xxxxxxxxxxx-1-xx |
||
Xxxxxxxx |
5-xxxxx-4,5-xxxxxxxxxxxxx-2-xxxx |
||
Xxxxxxxx |
5,5-xxxxxxxxxxxxxxxxxx xxxxxxxx |
||
Xxxxxxxxxx |
XX 718; XX 6008; Xxxxxxxxxx; |
5-xxxxx-1,3,6,7,8,9-xxxxxxxxx-2X-[1]xxxxxxxxxxx[2,3-x] [1,4]diazepin-2-on |
|
Benzfetamin |
(+)-N-benzyl-N-(2-fenyl-1-methylethy)-N-methylamin |
||
Benzylpiperazin |
1-benzylpiperazin |
||
Bromazepam |
7-brom-5-(2-pyridyl)-1,3-dihydro-2H-1,4-benzodiazepin-2-on |
||
Brotizolam |
2-brom-4-(2-chlorfenyl)-9-methyl-6H-thieno[3,2-ƒ][1,2,4]triazolo[4,3-a][1,4]diazepin |
||
Butobarbital |
5-butyl-5-ethylbarbiturová xxxxxxxx |
||
Xxxxxxxxx |
XX-798; |
4-[[7-xxxx-5-(2-xxxxxxxxxx)-2-xxx-1,3-xxxxxxx-1,4-xxxxxxxxxxxxx-3-xx]xxx]-4-xxx-xxxxxxxx xxxxxxxx |
|
Xxxxxxxxxxx |
7-xxxxx-5-(2-xxxxxxxxxx)-1,3-xxxxxxx-2X-1,4-xxxxxxxxxxxxx-2-xx |
||
Xxxxxxxx |
7-xxxxx-5-xxxxx-1-xxxxxx-1,3-xxxxxxx-2X-1,4-xxxxxxxxxxxxx-2-xx |
||
Xxxxxxxxx |
8-xxxxx-6-xxxxx-4X-[1,2,4]xxxxxxx[4,3-x][1,4]xxxxxxxxxxxxx |
||
Xxxxxxxxx |
X-(1-xxxxxxxxxxxxxxxxx)xxxxxxxx |
||
Xxxxxxxxxxxxx |
1-xxxxx-3-xxxxxxxxx-1-xx-4-xx-3-xx |
||
Xxxxxxxxxxxxxx |
(±)-2-(xxxxxxxxxx)-1-xxxxxxxxxxx |
||
Xxxxxxxxxxxxxxx |
xxxxx-7-xxxxx-5-(2-xxxxxxxxxx)-2-xxx-2,3-xxxxxxx-1X-1,4-xxxxxxxxxxxxx-3-xxxxxxxxxx |
||
Xxxxxxxxx |
7-Xxxxx-5-(2-xxxxxxxxxxx)-1,3-xxxxxxx-2X-1,4-xxxxxxxxxxxxx-2-xx |
||
Xxxxxxxxxxxxx |
(2X,3X)-2-xxxxx-3,4-xxxxxxxxxxxxxxxx |
||
Xxxxxxxxxxx |
(±)-2-(xxxxxxxxxx)-3-xxxxxxxxxxxx[2.2.1]xxxxxx |
||
Xxxxxxxxxxxx |
5-xxxxx-5-xxxxxxxxxxxxxxxx kyselina |
||
Fenproporex |
(+)-1-fenyl-2-[(2-kyanethyl)amino] xxxxxx |
||
Xxxxxxxxxxx |
7-xxxxx-5-(2-xxxxxxxxxx)-1-xxxxxx-1,3-xxxxxxx-2X-1,4-xxxxxxxxxxxxx-2-xx |
||
Xxxxxxxxxx |
7-xxxxx-2-[2-(xxxxxxxxxxxx)xxxxx]-5-(2-xxxxxxxxxx)-1,3-xxxxxxx-2X-1,4-xxxxxxxxxxxxx-2-xx |
||
XX-xxxxxx |
7-xxxxx-5-xxxxx-1-(2,2,2-xxxxxxxxxxxxx)-1,3-xxxxxxx-2X-1,4-xxxxxxxxxxxxx-2-xx |
||
XX-xxxxxxxx |
10-xxxx-11x-(2-xxxxxxxxxx)-2,3,7,11x-xxxxxxxxxxxxxxxxx[3,2-x][1,4]xxxxxxxxxxxxx-6(5X)-xx |
||
Xxxxxxxxxxxxxxx |
7-xxxxx-5-xxxxx-2-(xxxxxxxxxxx)-3X-1,4-xxxxxxxxxxxxx-4-xxxx |
||
Xxxxxxxxx |
7-xxxxx-5-xxxxx-1-xxxxxx-2-xxx-1,3-xxxxxxx-2X-1,4-xxxxxxxxxxxxx-3-xx-xxxxxxxxxxxxxxxx |
||
Xxxxxxx |
(2XX)-2-(2-xxxxxxxxxx)-2-(xxxxxxxxxxx)xxxxxxxxxx-1-xx |
||
Xxxxxxxxx |
11-xxxxx-12x-xxxxx-2,8-xxxxxxxx-8,12x-xxxxxxx-4X-[1,3]xxxxxxx[3,2-x][1,4]xxxxxxxxxxxxx-4,7(6X)-xxxx |
||
Xxxxxxxx |
7-xxxxx-5-xxxxx-1-xxxxxx-1X-1,5-xxxxxxxxxxxxx-2,4(3X,5X)-xxxx |
||
Xxxxxxxxxx |
5-(2-xxxxxxxxxx)-7-xxxxx-1,3-xxxxxxx-2X-1,4-xxxxxxxxxxxxx-2-xx |
||
Xxxxxxxxxx |
7-xxxxx-5-xxxxx-2-xxx-2,3-xxxxxxx-1X-1,4-xxxxxxxxxxxxx-3-xxxxxxxxxxx xxxxxxxx |
||
Xxxxxxxxxxx |
5-(2-xxxxxxxxxx)-7-xxxxx-1-xxxxxx-1,3-xxxxxxx-2X-xxxxxx[2,3-x][1,4]xxxxxxxx-2-xx |
||
Xxxxxxxxxx |
10-xxxxx-11x-(2-xxxxxxxxxx)-2,3,7,11x-xxxxxxxxxxxxxxxxx[3,2-x][1,4]xxxxxxxxxxxxx-6(5X)-xx |
||
Xxxxxxxxx |
XXX |
(-)-1-(xxxxxxxxxxxxx)-1,2-xxxxxxxxxxxx |
|
Xxxxxxxxxx |
6-(2-xxxxxxxxxx)-2-[(4-xxxxxxxxxxxxxxx-1-xx)xxxxxx]-8-xxxxx-2,4-xxxxxxx-1X-xxxxxxx[1,2-x][1,4]xxxxxxxxxxxxx-1-xx |
||
Xxxxxxxxx |
7-xxxxx-5-(2-xxxxxxxxxx)-3-xxxxxxx-1,3-xxxxxxx-2X-1,4-xxxxxxxxxxxxx-2-xx |
||
Xxxxxxxxxxxx |
7-xxxxx-5-(2-xxxxxxxxxx)-3-xxxxxxx-1-xxxxxx-1,3-xxxxxxx-2X-1,4-xxxxxxxxxxxxx-2-xx |
||
Xxxxxxxx |
5-(4-xxxxxxxxxx)-2,5-xxxxxxx-3X-xxxxxxx[2.1-α]-xxxxxxxx-5-xx |
||
Xxxxxxxxx |
7-xxxxx-5-xxxxx-1-xxxxxx-2,3-xxxxxxx-1X-1,4-xxxxxxxxxxxxx |
||
Xxxxxxxxx |
(±)-2-[(3-xxxxxxxxxxx)xxxxx]-1-xxxxxxxxxxx |
||
Xxxxxxxxxx |
2-xxxxxx-2-xxxxxxxxxxxx-1,3-xxxx-xxxxxxxxxx |
||
Xxxxxxxx |
X-(xxxxxxxxxxxxxx)-3-(2-xxxxx-1-xxxxxxxxxxx)xxxxxxxxxx |
||
Xxxxxxxxxxxxxxxxxx |
5-xxxxx-5-xxxxx-1-xxxxxxxxxxxxxxxxx xxxxxxxx |
||
Xxxxxxxxxxx |
3,3-xxxxxxx-5-xxxxxxxxxxxxxxx-2,4-xxxx |
||
Xxxxxxxxx |
8-xxxxx-6-(2-xxxxxxxxxx)-1-xxxxxx-4X-xxxxxxx[1,5-x][1,4]xxxxxxxxxxxxx |
||
Xxxxxxxxxxx |
5-xxxxx-1-xxxxxx-7-xxxxx-1,3-xxxxxxx-2X-1,4-xxxxxxxxxxxxx-2-xx |
||
Xxxxxxxxxx |
5-xxxxx-7-xxxxx-1,3-xxxxxxx-2X-1,4-xxxxxxxxxxxxx-2-xx |
||
Xxxxxxxxxx |
7-xxxxx-5-xxxxx-1,3-xxxxxxx-2X-1,4-xxxxxxxxxxxxx-2-xx |
||
Xxxxxxxx |
7-xxxxx-5-xxxxx-3-xxxxxxx-1,3-xxxxxxx-2X-1,4-xxxxxxxxxxxxx-2-xx |
||
Xxxxxxxx |
10-xxxxx-11x-xxxxx-2-xxxxxx-2,3,7,11x-xxxxxxxxxxxxxxxxx[3,2-x] [1,4]xxxxxxxxxxxxx-6(5X)-xx |
||
Xxxxxxx |
5-xxxxx-2-xxxxx-1,3-xxxxxxxxxx-4-xx |
||
Xxxxxxxxx |
7-xxxxx-5-xxxxx-1-(xxxx-2-xx-1-xx)-1,3-xxxxxxx-2X-1,4-xxxxxxxxxxxxx-2-xx |
||
Xxxxxxxxx |
xxxxxxx(2-xxxxxxxxx)xxxxxxxx |
||
Xxxxxxxx |
7-xxxxx-1-(xxxxxxxxxxxxxxxxx)-5-xxxxx-1,3-xxxxxxx-2X-1,4-xxxxxxxxxxxxx-2-xx |
||
Xxxxxxxxxxx |
(+)-1-(4-xxxxxxxxxxx)-2-(xxxxxxxxxx-1-xx)xxxxxx-1-xx |
||
Xxxxxxxxxxxxxxx |
5-xxxxx-5-(1-xxxxxxxxxxxx)xxxxxxxxxxx xxxxxxxx |
||
Xxxxxxxxx |
(XX)-7-xxxxx-5-xxxxx-3-xxxxxxx-1-xxxxxx-1,3-xxxxxxx-2X-1,4-xxxxxxxxxxxxx-2-xx |
||
Xxxxxxxxxx |
7-xxxxx-5-(xxxxxxxx-1-xx-1-xx)-1-xxxxxx-1,3-xxxxxxx-2X-1,4-xxxxxxxxxxxxx-2-xx |
||
Xxxxxxxxx |
8-xxxxx-6-(2-xxxxxxxxxx)-1-xxxxxx-4X-[1,2,4]xxxxxxxx[4,3-x][1,4]xxxxxxxxxxxxx |
||
Xxxxxxxxxx |
5-(1-xxxxxxxxxxx)-5-xxxxxxxxxxxxxxxx xxxxxxxx |
||
Xxxxxxxx |
X,X,6-xxxxxxxxx-2-(4-xxxxxxxxxxx)xxxxxxx[1,2-x]xxxxxxx-3-xxxxxxxx |
Xxxxxx xxxx xxxxxxxxxxxxxx látek xxxxxxxxx x&xxxx;xxxxx seznamu xx xxxxx případech, kdy xxxx xxxx mohou xxxxxxxxx.
Příloha č. 8 x xxxxxxxx xxxxx x. 463/2013 Xx.
Xxxxxx x. 8 xxxxxxxxx xxxxxxxxx
Xxxxxxxxx xxxxxxxxxx: |
Xxxxxxxx: |
||
1) |
xxxxx z xxxxxxxx látek: acetyldihydrokodein dihydrokodein ethyImorfin folkodin kodein nikodikodin nikokodin norkodein |
Mohou obsahovat xxxxx xxxx více xxxxxxx xxxxx (xxxxxxx xxxx xxxxxxxx) x xxxxxxxx omamné látky |
|
a) |
v xxxxx xxxxxxx, tobolce, xxxxxx, čípku, xxxx. x jiné xxxxxx xxxxx xxxxx xxxxxxxxxx 100 xx, |
||
x) |
x xxxxxxx xxxxx xxx xxxxxxxxxxx xxxxx xxx 2,5 % |
||
2) |
xxxxxxxxx |
x) |
Xxxxxxxx difenoxinu xxxxx xxxxxxxxxx v xxxxx xxxxxxx, xxxxxxx, xxxxxx, xxxxx, xxxx. v xxxx lékové xxxxx 0,5 mg. |
b) |
Množství xxxxxxx-xxxxxxx xxxx byt xxxxxxx 5 % x xxxxxxxx xxxxxxxxxxxx v xxxxx tabletě, xxxxxx, xxxxxx, xxxxx, popř. xxxx xxxxxx formě. |
||
3) |
difenoxylát |
a) |
Množství xxxxxxxxxxxx xxxxx přesáhnout x xxxxx tabletě, xxxxxxx, xxxxxx, čípku, xxxx. x xxxx xxxxxx xxxxx 2,5 xx. |
x) |
Xxxxxxxx xxxxxxx-xxxxxxx xxxx xxx nejméně 1 % x xxxxxxxx xxxxxxxxxxxx x xxxxx xxxxxxx, xxxxxxx, xxxxxx, xxxxx, popř. v xxxx lékové xxxxx. |
||
4) |
xxxxxxxxxxxxxxxx |
Xxxxxxxx xxxxxxxxxxxxxxxxx |
|
x) |
xxxxx xxxxxxxxxx 135 xx x xxxxx xxxxxxx, xxxxxxx, ampuli, xxxxx, xxxx. x xxxx lékové xxxxx. |
||
x) |
x xxxxxxx xxxxx xxx xxxxxxxxxxx vyšší xxx 2,5 %. |
||
Xxxxxxxxx xxxxx xxxxxxxxx žádnou xxxxxxxxxxxx xxxxx. |
|||
5) |
xxxxxx |
Xxxxxxxx xxxxxxx nesmí xxxxxxxxxx 0,1 % xxxxxxx. |
|
6) |
xxxxx xxxx xxxxxx |
x) |
Xxxxxxxx xxxxxxx xxxxx xxxxxxxxxx 0,2 %. |
b) |
Dále xxxxx xxxxxxxxx xxxxx xxxx xxxx xxxxxxx látek (xxxxxxx xxxx xxxxxxxx). |
||
Xxxxxx xxxxx v xxxxxxxxx xxxxxxxx xxxxx být xxxxxx xxxxxxx xxxx x takovém xxxxxxxx, xxx xxxxxxxx xxxxxxx xxxxxx |
|||
7) |
xxxxxxxxxxxxx xxxxxx x xxxxx |
x) |
Xxxxxxxx xxxx x xxxxxx xxxxx xxx xxxxx xxx 10 %. |
x) |
Xxxxxxxx ipekakuanhového xxxxxx xxxxx být xxxxx xxx 10 %. |
||
x} |
Xxxxxxxx xxxxx xxxx xxxx xxxxxxx látek (xxxxxxx xxxx ornamných) nesmí xxx xxxxx xxx 80%. |
||
8) |
xxxxxxxxx |
x) |
Xxxxxxxxx xxxxxxxxx xxxxx xxxxxxxxxx 100 xx x xxxxx xxxxxxx, xxxxxxx, ampuli, čípku, xxxx. v jiné Xxxxxx xxxxx. |
x) |
Xxxxxxxxx xxxxxxxxxxxxxx x xxxxxxxxx xxxx xxx xxxxxxx xxxxxx xxxx xxxxx xxx xxxxxxxxx. |
Xxxxxx xxxxxxxxxxxx vyrobených xxxxxxxxx, xxxxxxx stupeň xxxxxx xx xxxxx xxx D4 xxxx XX2.
Xx. XX
Xxxx xxxxxxxx xxxx xxxxxxxx x xxxxxxx xx směrnicí Xxxxxxxxxx xxxxxxxxxx x Xxxx (EU) 2015/1535 xx xxx 9. xxxx 2015 x xxxxxxx xxx xxxxxxxxxxx xxxxxxxxx x xxxxxxx xxxxxxxxxxx předpisů a xxxxxxxx xxx xxxxxx xxxxxxxxxx společnosti.
Čl. XX xxxxxx xxxxxxx xxxxxxxxx x. 46/2017 Sb. x xxxxxxxxx xx 1.3.2017
Xx. XX
Xxxx nařízení xxxx xxxxxxxx x xxxxxxx xx xxxxxxxx Xxxxxxxxxx xxxxxxxxxx a Xxxx (XX) 2015/1535 xx dne 9. xxxx 2015 x xxxxxxx xxx poskytování xxxxxxxxx x oblasti xxxxxxxxxxx xxxxxxxx x xxxxxxxx pro služby xxxxxxxxxx xxxxxxxxxxx.
Xx. XX xxxxxx právním xxxxxxxxx x. 30/2018 Sb. x xxxxxxxxx xx 8.3.2018
Čl. II
Toto xxxxxxxx xxxx oznámeno v xxxxxxx xx směrnicí Xxxxxxxxxx xxxxxxxxxx a Xxxx (EU) 2015/1535 xx xxx 9. xxxx 2015 x xxxxxxx xxx xxxxxxxxxxx xxxxxxxxx x xxxxxxx xxxxxxxxxxx předpisů x xxxxxxxx pro xxxxxx xxxxxxxxxx společnosti.
Čl. XX xxxxxx xxxxxxx xxxxxxxxx x. 242/2018 Xx. x xxxxxxxxx xx 25.10.2018
Čl. XX
Xxxxxxxxx xxxxxxx
Xxxx xxxxxxxx xxxx xxxxxxxx x xxxxxxx se xxxxxxxx Xxxxxxxxxx parlamentu x Xxxx (XX) 2015/1535 xx xxx 9. září 2015 x xxxxxxx xxx xxxxxxxxxxx xxxxxxxxx v xxxxxxx technických předpisů x předpisů xxx xxxxxx xxxxxxxxxx společnosti.
Čl. XX xxxxxx xxxxxxx xxxxxxxxx č. 184/2021 Xx. x xxxxxxxxx xx 3.6.2021
Xxxxxx xxxxxxx x. 463/2013 Xx. nabyl xxxxxxxxx dnem 1.1.2014.
Ve xxxxx xxxxxx právního xxxxxxxx xxxx xxxxxxxxxx xxxxx x xxxxxxxx xxxxxxxxxxx xxxxxxx předpisem x.:
243/2015 Xx., xxxxxx xx xxxx xxxxxxxx xxxxx x. 463/2013 Xx., o seznamech xxxxxxxxxx xxxxx
x xxxxxxxxx xx 1.10.2015
46/2017 Xx., xxxxxx se xxxx xxxxxxxx vlády č. 463/2013 Xx., x xxxxxxxxx xxxxxxxxxx látek, xx znění xxxxxxxx xxxxx č. 243/2015 Xx.
x účinností xx 1.3.2017 x xxxxxxxx xxxxxxxxx xxxxxxxxxx, xxxxx xxxxxxxx xxxxxxxxx 1.5.2017
30/2018 Xx., xxxxxx xx xxxx xxxxxxxx vlády x. 463/2013 Xx., x xxxxxxxxx xxxxxxxxxx xxxxx, ve znění xxxxxxxxxx xxxxxxxx
x účinností xx 8.3.2018
242/2018 Xx., xxxxxx xx xxxx xxxxxxxx xxxxx x. 463/2013 Xx., x xxxxxxxxx návykových xxxxx, xx xxxxx pozdějších xxxxxxxx
x xxxxxxxxx xx 25.10.2018
184/2021 Xx., kterým xx xxxx nařízení xxxxx x. 463/2013 Xx., x xxxxxxxxx xxxxxxxxxx xxxxx, xx xxxxx xxxxxxxxxx předpisů
s xxxxxxxxx xx 3.6.2021
159/2022 Xx., xxxxxx se xxxx nařízení xxxxx x. 463/2013 Sb., x xxxxxxxxx xxxxxxxxxx xxxxx, xx znění xxxxxxxxxx předpisů
s účinností xx 1.7.2022
228/2023 Xx., xxxxxx xx xxxx xxxxxxxx xxxxx x. 463/2013 Xx., x xxxxxxxxx xxxxxxxxxx xxxxx, xx xxxxx pozdějších xxxxxxxx
x xxxxxxxxx xx 1.8.2023
52/2024 Sb., xxxxxx xx xxxx xxxxxxxx xxxxx x. 463/2013 Xx., x xxxxxxxxx xxxxxxxxxx xxxxx, xx xxxxx pozdějších xxxxxxxx
x xxxxxxxxx xx 6.3.2024 x 1.1.2025
Xxxxx xxxxxxxxxxxx xxxxxxxx xxxxx jiných xxxxxxxx xxxxxxxx x xxxxxxxx xxxx xxxxxxxxxxxxx, xxxxx xx xxxx xxxxxx derogační xxxxx xxxxx xxxxxxxxx xxxxxxxx xxxxxxxx.
1) Xxxxxxxx xxxxxx x xxxxxxxx látkách, xxxxxxxxx xxx č. 47/1965 Sb., xx xxxxx Xxxxxxxxx x xxxxxxx Jednotné xxxxxx x xxxxxxxx xxxxxxx, xxxxxxxxxxx pod č. 458/1991 Sb.
2) Xxxxxx x xxxxxxxxxxxxxx xxxxxxx, vyhlášená xxx č. 62/1989 Sb.
3) Xxxxxxx xxxxxxxxxx Xxxx 2004/757/XXX ze xxx 25. xxxxx 2004, xxxxxx xx xxxxxxx xxxxxxxxx ustanovení xxxxxxxx xx xxxxx xxxxxxxxxx xxxxxxx xxxxxxxxx xxxx a xxxxxx x xxxxxxx xxxxxxxxxxxx xxxxxxx x xxxxxxx.
Xxxxxxxx Xxxxxxxxxx parlamentu x Xxxx (EU) 2017/2103 xx xxx 15. xxxxxxxxx 2017, xxxxxx xx mění xxxxxxx xxxxxxxxxx Xxxx 2004/757/SVV x xxxxx xxxxxxxx xx definice xxxxx xxxx xxxxxxxxxxxxx xxxxx x xxxxxxx rozhodnutí Xxxx 2005/387/XXX.
Xxxxxxxx Xxxxxx x xxxxxxxxx xxxxxxxxx (XX) 2019/369 ze xxx 13. xxxxxxxx 2018, xxxxxx xx xxxx xxxxxxx xxxxxxxxx xxxxxxxxxx Xxxx 2004/757/SVV, xxxxx jde x xxxxxxxx xxxxxx xxxxxxxxxxxxxxx xxxxx do xxxxxxxx xxxxx.
Xxxxxxxx Xxxxxx x xxxxxxxxx xxxxxxxxx (XX) 2020/1687 xx xxx 2. xxxx 2020, xxxxxx xx xxxx xxxxxxx xxxxxxxxx rozhodnutí Xxxx 2004/757/SVV, xxxxx xxx x xxxxxxxx xxxx xxxxxxxxxxxxx xxxxx X,X-xxxxxxx-2-[[4-(1-xxxxxxxxxxxx)xxxxx]xxxxxx]-5-xxxxx-1 X-xxxxxxxxxxxx-1-xxxxxxxxx (xxxxxxxxxxxx) xx xxxxxxxx drogy.